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1 Introduction 
For decades, microorganisms have been exploited for the production of food 
ingredients. Along with the development of genetic engineering, the utilization of 
organisms is no longer limited only to the food industry. Genetic engineering has 
enabled the modification of organisms to produce the desired product with higher titer 
and even express genes derived from another species. Aspergillus niger is one of the 
most used filamentous fungi in industrial biotechnology and it has been used to produce 
certain organic acids, such as gluconic and citric acid. Citric acid is a widely used product 
in different industries. Moreover, A. niger can also produce various enzymes, such as 
pectinases and amylases. 
Hexaric and hexuronic acids are sugar acids derived by oxidizing a sugar. The molecular 
formula for hexaric acid is C6H10O8 and for hexuronic acid is C6H10O7. Hexaric acids have a 
carboxyl group both at C1 and C6, whereas hexuronic acids have an aldehyde group at C1 
and carboxyl group at C6. Examples of hexaric and hexuronic acid are galactaric acid and 
D-galacturonic acid, respectively (Figure 1). 
 
 
Figure 1 Structural formula of galactaric acid and acyclic D-galacturonic acid. 
 
D-galacturonic acid is one of the main constituent of pectin, which can be obtained from 
inexpensive citrus peel and sugar beet pulp. Galactaric acid, on the other hand, is an 
interesting material, because it and its derivatives have many potential applications, 
especially in polymer synthesis. The filamentous fungus A. niger can be engineered to 
produce galactaric acid from galacturonic acid, but the mould itself catabolizes galactaric 
acid lowering the yield (Mojzita et al., 2010). Therefore, the production of galactaric can 
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be improved by disrupting the galactaric acid catabolism, but the pathway in A. niger is 
still unknown. The ability to utilize mould in the production of value-added products 
directly from inexpensive raw materials such as pectin would be advantageous. 
The objectives of this Master’s thesis were to unravel the pathway for galactaric acid 
catabolism in A. niger by targeted deletion of the genes which are upregulated on 
galactaric acid, characterize the proteins encoded by these genes, characterize mutant 
strains and construct a galactaric acid producing strain. A. niger strains were engineered 
using homologous recombination and CRISPR/Cas9 genome editing tool. 
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LITERATURE REVIEW 
2 Aspergillus niger 
Aspergilli are widely used for the production of food ingredients, enzymes and 
antibiotics. They are tolerant towards acids and have a broad substrate spectrum. Two 
industrially important Aspergilli are Aspergillus niger and Aspergillus oryzae. They both 
have GRAS (generally recognized as safe) status, which is an advantage when planning 
and designing new processes and products. For example, new fermentation processes 
and products utilizing these fungi are more easily approved by the authorities than 
processes utilizing organism without GRAS-status. A. niger has been used in enzyme and 
organic acid production. (Knuf and Nielsen, 2012) It is also used for biotransformations 
and waste treatment (Schuster et al., 2002). A. oryzae has been used in food industry for 
sake, soy sauce and miso production for several centuries in Japan. (Knuf and Nielsen, 
2012) In this chapter the focus is going to be on A. niger. 
A. niger is composed of black-spored Aspergilli. It is a haploid, asexual filamentous 
fungus (Mable and Otto, 1998; Meyer et al., 2007). A. niger reproduces by forming 
spores called conidia, which are uninucleates (Nga et al., 1975). It grows aerobically on 
organic matter and can be found in soil, compost and on decaying plant material. 
A. niger is able to grow in the wide temperature range (6 – 47 °C) and pH range (pH 1.4 –
9.8). Its optimum growth temperature is at 35 – 37 °C. (Schuster et al., 2002)  
2.1 Industrial applications 
 In industry, A. niger has been used for citric acid, gluconic acid and industrial enzyme 
production. Another interesting application is using the fungus in waste treatment. 
In 1919, citric acid was produced for the first time by fermentation with A. niger. The 
wild-type A. niger ATCC 1015 is capable of producing citric acid (Andersen et al., 2011). 
Citric acid is mainly used in food and beverage industries as a primary acidifying agent, 
for example, in soft drinks, desserts and wine. (Schuster et al., 2002) It is also used in 
cosmetics, in the pharmaceutical industry as antioxidants, in the detergent industry as a 
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phosphate substitute, and in the chemical industry as a foaming agent (Max et al., 
2010). In 2007, the annual production of citric acid was over 1.6 million tons and its 
demand is still increasing due to its numerous applications and the potential usage of 
citric acid in biopolymers, for drug delivery, tissue engineering for culturing a variety of 
cells and other biomedical applications (Dhillion et al., 2010; Knuf and Nielsen, 2012).  
Citric acid is mainly produced by submerged fermentation (SmF) with A. niger using a 
media containing glucose or sucrose. However, small- and medium-scale industries use 
surface fermentation (SF) for citric acid production, because the operation is easier, 
energy costs are lower and only simple equipment is needed. In the SF, A. niger grows as 
a thick floating mycelia mat on the surface of the growth media trays, which are on the 
shelves of the fermentation chambers. The SF is not suited for large-scale production, 
because the production would be unprofitable. It requires a large space and is time-
consuming. Furthermore, it is vulnerable to contaminations and a large amount of heat 
is generated. The SmF requires lower investment and maintenance costs compared to  
the SF. (Max et al., 2010; Dhillion et al., 2010) Recently, there is an increased interest of 
using solid-state fermentation (SSF) for citric acid production. In the SSF, 
microorganisms grow on solid materials without the presence of free liquid. The SSF has 
many advantages over the SmF, such as solid waste management, reduced wastewater 
production, wide range of low-cost media, higher yield, production of high value 
products and lower energy requirements. (Dhillion et al., 2010; Torrado et al., 2011) In 
addition, in the SSF aeration is higher and low water activity reduces the risk of bacterial 
contamination (Torrado et al., 2011). On the other hand, scale-up and controlling the 
process conditions are difficult in the SSF compared to the SmF (Dhillion et al., 2010). 
Fermentors, such as, Erlenmeyer conical flasks, glass incubators, trays, rotating and 
horizontal drum bioreactors, packed bed column bioreactor, single-layer packed bed and 
multilayer packed bed have been used for citric acid production using SSF. The SSF 
process still requires improvements in several areas, for example yield and automation 
of the process, in order to increase its feasibility for industrial production. (Dhillion et al., 
2010).  
Similar to citric acid, gluconic acid is also used in the food, beverage and pharmaceutical 
industries as an acidifying, flavour-enhancing and leavening agent (Roukas, 2000; 
Ramachandran et al., 2006). Cement, textile and chemical industries also utilize gluconic 
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acid (Singh et al., 2003). Annually, 60 000 tonnes of gluconic acid is produced and of its 
salt derivatives sodium gluconate is the most common. Sodium gluconate can chelate 
calcium and other di- and trivalent metal ions. Other gluconic acid derivatives are 
glucono-δ-lactone, calcium gluconate and iron gluconate. Glucono-δ-lactone is used in 
dairy industry for cheese curd formation and improving heat stability of milk. Calcium 
gluconate is used in calcium therapy for treating calcium deficiency. Similarly, iron 
gluconate is used in iron therapy. For example, zinc gluconate is used for treating the 
common cold and diseases caused by zinc deficiency. (Ramachandran et al., 2006) 
Gluconic acid is mainly produced by SmF with A. niger, in which D-glucose is oxidized to 
glucono-δ-lactone by glucose oxidase. Glucono-δ-lactone is then hydrolysed 
spontaneously near neutral pH or by lactonase to gluconic acid. Oxygen availability and 
pH are key parameters in gluconic acid production, since glucose oxidase needs oxygen 
for the oxidation of glucose and accumulation of organic acids produced by A. niger 
depends on the pH. If the pH falls below 3.5, the citric acid cycle will be triggered 
facilitating citric acid formation. Optimum pH for gluconic acid production is 5.5. 
(Ramachandran et al., 2006). Singh et al. (2003) have investigated the production of 
gluconic acid using SmF, semisolid-sate fermentation (SmSF), SF and SSF with A. niger 
and varying glucose concentrations (40, 80, 120, 200 and 220 g/l). The gluconic acid 
production was the highest in all fermentation types when the initial glucose 
concentration was 120 g/l. Glucose utilization was most efficient in SmSF (89-97 %) and 
glucose up-take was higher in the SmF and the SmSF than in the SF and the SSF. 
Nevertheless, the conversion of glucose and gluconic acid yield was better in the SF and 
the SSF. The highest gluconic acid yield 94.7 % and concentration 106.5 g/l was obtained 
with the SSF. Similar to citric acid production, SSF is a promising fermentation type for 
gluconic acid production. 
In the past years, there has been interest in using agricultural products and residues, 
such as, fig (the fruit of fig tree Figus carica), citrus and kiwi fruit peel and apple and 
grape pomace for citric acid and gluconic acid production utilizing A. niger (Roukas, 
2000). For example, with orange peel Rivas et al. (2008) were able to obtain 9.2 g/l of 
citric acid by SmF. Furthermore, Torrado et al. (2011) were able to achieve higher citric 
acid yield with SSF (193.2 mg/ g dry orange peel) than with SmF (73.6 mg/g dry orange 
pel) from orange peel. When fig was used as the substrate for SSF the obtained citric 
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acid and gluconic acid yield was 64 g/kg dry fig and 490 g/kg dry fig respectively (Roukas, 
2000).  
In addition to organic acids, A. niger is also efficient in producing high amounts of 
hydrolysing enzymes, such as amylases, pectinases, hemicellulases and xylanases. For 
example, A. niger CBS 513.88 is an industrial enzyme-producing strain, which was 
derived from A. niger NRRL 3122 developed for glucoamylase A production. (Andersen 
et al., 2011) The enzymes produced by A. niger have wide industrial applications, 
including glucoamylases used in the glucose syrup and alcohol industry and different 
pectinases, such as pectin esterases, endo- and exopolygalacturonidases and pectin 
lyases, used in wine and fruit juice production. Furthermore, the hemicellulases from A. 
niger can be added to dough, improving the doughs properties. (Schuster et al., 2002) 
Besides using A. niger as a production organism, the fungus has been used in waste 
treatment to remove metals from the environment. It has been listed as one of the top 
metal biosorbents. A. niger is able to adsorb metals to the cell wall components. 
Moreover, organic acids produced by the fungus form complexes with metals and leach 
or precipitate metals from materials. (Price et al., 2001) Price et al. (2001) have studied 
six different fungi for their ability to remove copper and zinc from swine wastewater. 
Their results indicated that A. niger is the most efficient fungi for removing copper, thus 
further experiment with zinc absorption were conducted with A. niger only. It is known 
that A. niger possess a copper metallothionein, but the protein or the gene has not been 
sequenced. Metallothioneins are metal binding proteins which have been suggested to 
detoxify metals. Both living and dead A. niger were able to remove copper, but living 
fungus absorbed five times more copper on a mass basis. A. niger was capable of 
removing 91 % of the copper and 70 % of the zinc from treated swine effluent in 24 h.  
Another potential waste treatment application utilizes A. niger to remove coloured dye 
substances in textile wastewater. A. niger is capable of adsorbing dyes and possibly also 
biodegrading them. (Assadi and Jahangiri, 2001; Omar, 2016) Assadi and Jahangiri (2001) 
have reported that A. niger could decolorize 97 % of textile wastewater in 20 h in airlift 
fermenter. According to Omar (2016), A. niger showed a strong ability to decolorize 
various reactive dyes (83-99 %) and grew well in a high dye concentration (500 mg/l). 
Carbon source and acidic conditions improved the decolorization in both reports.  
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3 Pectin-rich residues as a raw material 
3.1 Structure of pectin 
Pectin is structurally the most complex family of polysaccharides in nature and it can be 
found in plant cell walls. Pectin consist of a α-1,4-linked D-galacturonic acid backbone 
with sugar side chains. Approximately 70 % of pectin mass consists of galacturonic acid. 
There are five different types of pectin classified based on their structure: 
homogalacturonan (HG), xylogalacturonan (XGA), apiogalacturonan (AP), 
rhamnogalacturonan I (RG-I) and rhamnogalacturonan II (RG-II). HG is the most 
abundant and the simplest pectin since it is a linear galacturonic acid chain, which is 
partially methylesterified and acetylated. XGA is a HG substituted with xylose and AP is a 
HG substituted with D-apiofuranose. RG-II is the most structurally complex pectin. 
(Mohnen, 2008) It consists of a HG backbone with side chains consisting of 12 different 
sugars in over 20 different linkages. The sugars are D-glucuronic acid, L-rhamnose, 
D-galactose, L-arabinose, L-fucose, D-apiose, L-aceric acid, 2-O-methyl L-fucose, 2-O-
methyl D-xylose, L-galactose, 2-keto-3-deoxy-D-lyxo-heptulosaric acid and 2-keto-3-
deoxy-D-manno-octulosonic acid. (O’Neill et al., 2004) In contrast to other pectin types, 
the RG-I backbone consists of a α-1,4-linked D-galacturonic acid and α-1,2-linked 
L-rhamnose repeating disaccharide unit with side chains consisting of various amount of 
L-arabinose and D-galactose. (Mohnen, 2008) 
3.2 Galacturonic acid pathways 
The main constituent of pectin, D-galacturonic acid, can be catabolized by some 
microorganisms. For example, the filamentous fungus A. niger is naturally capable of 
hydrolyzing pectin and catabolizing D-galacturonic acid to pyruvate and glycerol (Figure 
2). In this reductive pathway, D-galacturonate (salt of galacturonic acid) is first reduced 
to L-galactonate by D-galacturonate reductase and then L-galactonate dehydratase 
removes a water molecule generating 3-deoxy-L-threo-hex-2-ulosonate. Next 2-keto-3-
deoxy-L-galactonate aldolase splits 3-deoxy-L-threo-hex-2-ulosonate to pyruvate and 
L-glyceraldehyde. Finally, L-glyceraldehyde is reduced to glycerol by glyceraldehyde 
reductase. (Richard and Hilditch, 2009) 
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Figure 2 The fungal pathway for D-galacturonic acid catabolism, for example, in 
Aspergillus niger. D-galacturonate is converted to pyruvate and L-glyceraldehyde, which 
is further reduced to glycerol.  (Richard and Hilditch, 2009, modified) 
 
Other microorganisms such as Agrobacterium tumefaciens and Pseudomonas syringae 
can also catabolize D-galacturonic acid through an oxidative pathway (Figure 3). In the 
oxidative pathway, D-galacturonate is oxidized by D-galacturonate dehydrogenase 
forming D-galactaro-1,5-lactone, which rearranges in solution to more stable 
D-galactaro-1,4-lactone (Boer et al., 2010; Parkkinen et al., 2011). D-galactaro-1,5-
lactone can also be converted to D-galactaro-1,4-lactone by D-galactarolactone 
isomerase (Bouvier et al., 2014). A. tumefaciens has a galactarolactone cycloisomerase 
which can convert D-galactaro-1,4-lactone directly to 3-deoxy-2-keto-L-threo-hexarate 
(Andberg et al., 2012). Previously it has been assumed that galactaro-1,4-lactone can 
hydrolyses spontaneously at an alkaline pH or with the aid of lactonase to galactarate 
(Boer et al., 2010). A water molecule is then removed from galactarate by galactarate 
dehydratase in a dehydration reaction forming 3-deoxy-2-keto-L-threo-hexarate or 
3-deoxy-2-keto-D-threo-hexarate. However, it is not known which isomer is produced in 
the oxidative pathway. (Andberg et al., 2012) It is still unclear whether A. tumefaciens or 
P. syringae also catabolize galacturonate via galactarate. Two types of galactarate 
dehydratases forming L-threo- and D-threo-hexarates have been discovered. 
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Dehydratase TalrD/GalrD from Salmonella typhimurium converts galactarate to 3-deoxy-
2-keto-L-threo-hexarate (Wen et al., 2007). GalrD-II from Oceanobacillus iheyensis 
(Rakus et al., 2009) and GarlD-III from A. tumefaciens (Groninger-Poe et al., 2014) 
convert galactarate to 3-deoxy-2-keto-D-threo-hexarate. In the following steps of 
galacturonic acid catabolism, 5-dehydro-4-deoxy-glucarate dehydratase dehydratates 
and decarboxylates 3-deoxy-2-keto-L-threo-hexarate to 2-ketoglutarate semialdehyde. 
The semialdehyde is then subsequently oxidized to 2-keto-glutarate by 
2,5-dioxovalerate dehydrogenase. (Richard and Hiditch, 2009) 
 
 
Figure 3 The oxidative pathway of D-galacturonic acid catabolism. In this pathway, 
D-galacturonate is oxidized to galactaro-1,5-lactone which can be enzymatically or non-
enzymatically rearranged to galactaro-1,4-lactone. Galactaro-1,4-lactone then 
hydrolyses spontaneously or with the aid of lactonase to 3-deoxy-2-keto-L-threo-
hexarate. However, in Agrobacterium tumefaciens galactaro-1,4-lactone is converted to 
3-deoxy-2-keto-L-threo-hexarate. 
 
E. coli catabolizes galacturonic acid through an isomerase pathway (Figure 4). In E. coli, 
D-galacturonate is converted to pyruvate and D-glyceraldehyde-3-phosphate in five 
steps. First, uronate isomerase converts galacturonate to D-tagaturonate. Next, 
D-tagaturonate reductase reduces D-tagaturonate to D-altronate, which is further 
converted to 3-doexy-D-erythro-hex-2-ulosonate by D-altronate dehydratase. Then 
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2-keto-3-deoxy-D-gluconate kinase phosphorylates 3-deoxy-D-erythro-hex-2-ulosonate 
to 3-deoxy-D-erythro-hex-2-ulosonate-6-phosphate, which is finally cleaved to pyruvate 
and D-glyceraldehyde-3-phosphate by 2-keto-3-deoxy-6-phosphogluconate aldolase. 
(Richard and Hilditch, 2009) 
 
 
Figure 4 The isomerase pathway of D-galacturonic acid catabolism in Escherichia coli. In 
the pathway, D-galacturonate is converted to pyruvate and D-glyceralde-3-phosphate. 
(Richard and Hilditch, 2009, modified)  
3.3 Applications of pectin-rich residues  
Citrus juice production and sugar beet processing produce pectin-rich residues, which 
are mainly used as animal feed by the agricultural industry. Food industry also uses 
pectin produced from citrus peel as a gelling agent (Richard and Hilditch, 2009). Sugar 
beet pulp contains 24 % (Doran-Peterson et al., 2008) and citrus processing waste (CPW) 
contains 25 % of pectin on a dry mass basis (Pourbafrani et al., 2010). Processing the 
residues is energy consuming and the costs are high, because the residues require 
drying and pelletizing to prevent degradation (Richard and Hilditch, 2009). Instead of 
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processing the residues for applications such as animal feed, it would be more 
economical to find an alternative use.  
Galacturonic acid in pectin-rich residues can be converted to useful compounds 
exploiting microorganisms. With recombinant bacteria, D-galacturonic acid can be 
converted to ethanol and galactaric acid. E. coli KO11, Klebsiella oxytoca P2 and Erwinia 
chrysanthemi EC 16 can produce ethanol with yields of 0.19, 0.12 and 
0.16 g ethanol/g galacturonic acid, respectively. Using E. coli KO11 40 g/l ethanol could 
also be produced from sugar beet pulp treated with fungal enzymes in 24 h. (Doran et 
al., 2000) Recombinant E. coli can also be used to produce galactaric acid from sugar 
beet residue. The galactaric acid can then be further converted chemically to adipic acid 
by a deoxydehydration reaction catalysed by an oxorhenium complex reaction followed 
by a Pt/C-catalyzed hydrogenation. (Zhang et al., 2016) 
For ethanol production, S. cerevisiae would be an excellent organism, because it can 
tolerate high substrate and ethanol concentrations and low pH and oxygen levels. 
However, S. cerevisiae cannot naturally ferment galacturonic acid. (Edwards and Doran-
Peterson, 2012) Therefore, it would need to be engineered by introducing a 
heterologous pathway. Furthermore, S. cerevisiae may not be able to assimilate 
galacturonic acid, hence, a plasma membrane galacturonic acid transporter should also 
be introduced. (van Maris et al., 2006) 
Galacturonic acid can also be converted to L-ascorbic acid (Kuivanen et al., 2015) and 
galactaric acid (Mojzita et al., 2010) by genetically engineered A. niger. Kuivanen et al. 
(2015) engineered A. niger to produce L-ascorbic acid (vitamin C) directly from 
galacturonic acid and CPW. First, the second enzyme L-galactonate dehydratase of the 
fungal galacturonic acid pathway was deleted. Then the heterologous enzymes 
L-galactono-1,4-lactone lactonase and L-galactono-1,4-lactone dehydrogenase from the 
plant L-ascorbic acid pathway were introduced into  A. niger ATCC 1015 ΔpyrG strain. 
L-gulono-1,4-lactone lactonase from animal L-ascorbic acid pathway was also introduced 
into the A. niger instead of L-galactono-1,4-lactone lactonase. As a result, A. niger 
metabolized galacturonate to L-galactonate, L-galactono- 1,4-lactone and finally to 
L-ascorbic acid. Kuivanen et al. (2015) achieved a titre of 170 mg/l L-ascorbic acid. 
Production of galactaric acid by A. niger will be discussed in chapter 4.2. 
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4 Galactaric acid 
4.1 Applications of galactaric acid and its derivatives 
Galactaric acid, also known as meso-galactaric acid or mucic acid, is an aldaric acid, 
which is used as chelator in skin care products (Sauermann et al., 2004), formerly in 
the1920s as leavening agent in self-rising flour and in dyeing textiles (Anonymous, 1922) 
and as a sequestering agent (Van Es et al., 2015). It also has potential applications in 
polymer synthesis as a platform chemical, which are probably the most important 
applications. 
Galactaric acid can be used to synthetize various types of polyhydroxypolyamides 
(hydroxylated nylons) with slightly different properties (Ogata et al., 1997; Kiely et al., 
2000). Galactaric acid can also be converted to several compounds, for example, adipic 
acid (Shiramizu and Toste, 2013; Li et al., 2014), furan-2,5-dicarboxylic acid (FDCA) 
(Lewkoswski, 2001), 2,3,4,5-tetra-O-methylgalactaric acid (Mancera et al., 2003), 
2,3,4,5-tetra-O-acetylgalactaric acid (Mehtiö et al., 2015), dibutyl 2,5-furandicarboxylate 
and dibutyl 2,3-furandicarboxylate (Taguchi et al., 2008). All these compounds can be 
polymerized. Derivatives of galactaric acid have numerous applications. For example, 
adipic acid is primary used in the production of polyamide nylon-6,6. Other usages are in 
the production of polyurethane, as a plasticizer in polyvinyl chloride (PVC) and polyvinyl 
butyral (PVB) production and as an additive in cosmetics, gelatins, lubricants, fertilizers, 
adhesives, insecticides, paper and waxes. (Van de Vyver and Román-Leshkov, 2013) 
Similar to adipic acid, FDCA also has many applications. FDCA is an ingredient of fire 
foam with applications in both pharmacology and polymer synthesis (Lewkoswski, 
2001). In pharmacology, it is utilized in the preparation of artificial veins for 
transplantation (Fraefel et al., 2983). In polymer production, FDCA could replace widely 
used fossil based terephthalic acid (Wu et al., 2014). Polyethylene furanoate (PEF) 
produced from FDCA has similar properties as polyethylene terephthalate (PET), making 
PEF a promising product with the potential to replace PET in making plastic bottles. 
(Anonymous, 2015; Liu B. et al., 2015) This would be more sustainable since FDCA can 
be produces from bio-based materials.  
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4.2 Production of galactaric acid 
Galactaric acid is currently produced commercially from D-galactose by oxidation with 
nitric acid (Acree, 1931), which is an expensive process and, moreover, produces toxic 
waste. Alternatively, chlorine could be used to oxidize galactose to galactaric acid with a 
nitroxide catalyst with the yield of 75-80 % (Nabyl et al., 2002). Galactaric acid could also 
be produced from D-galacturonic acid by electrolytic oxidation with 80 % yield (Van Es et 
al., 2015).  
Inexpensive pectin-rich residues could provide a cost effective alternative for producing 
galactaric acid. A method of producing galactaric acid utilizing biotechnology is to 
genetically engineer filamentous fungi for the production. Mojzita et al. (2010) have 
genetically engineered Trichoderma reesei and A. niger for galactaric acid production by 
disrupting D-galacturonate catabolic pathway. They deleted a gene which encodes D-
galacturonate reductase, gar 1 in T. reesei and gaaA in A. niger, and expressed the 
bacterial gene udh encoding D-galacturonate dehydrogenase derived from 
A. tumefaciens in T. reesei and the codon-optimized udh gene in A. niger (Figure 5). 
D-galacturonate dehydrogenase converted galacturonic acid to galactaro-lactone which 
then spontaneously hydrolysed to galactaric acid. Mojzita et al. (2010) obtained the 
yield of 1.08 g galactarate/g galacturonate with T. reesei in 211 h, whereas with A. niger 
only 0.16 g galactarate/g galacturonate in 4 days. They suggested that A. niger 
catabolizes galactaric acid, resulting in a poor intracellular and extracellular 
accumulation of galactaric acid and thus a lowered yield. As a conclusion, in the case of 
A. niger, catabolism of galactaric acid should be disrupted in order to obtain better 
production yields. However, this catabolic pathway is still unknown. If galactaric acid can 
be produced by A. niger, the downstream processing would be simplified as galactaric 
acid precipitates at a low pH. 
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Figure 5 Production of galactaric acid with genetically engineered Trichoderma reesei 
and Aspergillus niger by disrupting D-galacturonic acid catabolism. Gene coding 
D-galacturonate reductase was deleted and a bacterial gene coding D-galacturonate 
dehydrogenase was expressed in both strains. (Mojzita et al., 2010, modified) 
 
Galactaric acid can also be produced by engineered recombinant E. coli from sugar beet 
residue (Zhang et al., 2016). Overexpressing the udh from A. tumefaciens in the E. coli 
BL21(DE3), resulted in the conversion of 5, 10 and 20 g/l of pure D-galacturonic acid to 
4.3, 8.3 and 11.5 g/l galactaric acid respectively in 48 h. The obtained yield was lower 
than the theoretical yield which was speculated to be due to the native catabolism of 
galacturonic and galactaric acid in E. coli. Therefore, to improve galactaric acid 
production the genes uxaC encoding uronoate isomerase in the galacturonic acid 
catabolic pathway and garD encoding D-galactarate dehydrogenase in the galactaric acid 
catabolic pathway were deleted from E. coli BL21(DE3). In a medium containing 10 g/l 
glucose, 10 g/l L-arabinose and 10 g/l D-galacturonic acid, the E. coli BL21(DE3) udh 
strain converted 68.5 % of the D-galacturonic acid to galactaric acid with a titer of 7.4 g/l 
and the E. coli BL21(DE3) ΔuxaC ΔgarD udh strain converted 95.4 % of the D-galacturonic 
acid to galactaric acid with a titer of 10.3 g/l in 48 h. Sugar beet residue treated with a 
combination of cellulose, pectinase and Viscoayme® L in 50 mM citrate buffer at 50 °C 
produced a mixture of 22 % glucose, 17.4 % L-arabinose and 16.5 % D-galacturonic acid 
from the total residue. Using the supernatant of the enzyme treatment as the substrate, 
E. coli was able to convert 86 % of the D-galacturonic acid to galactaric acid in 48 h. The 
produced amount of galactaric acid was 6.9 g/l from 7.8 g/l of D-galacturonic acid. 
(Zhang et al., 2016) 
4.3 Catabolism of galactaric acid in microorganisms 
E. coli and A. tumefaciens are capable of catabolizing galactaric acid. In A  tumefaciens, 
galactaric acid may be formed as an intermediate in the galacturonic acid pathway when 
D-galacturonate is converted to galactarate in three steps. Catabolism of galactaric acid 
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in A. tumefaciens was described in the previous chapter (Figure 3). The first step of the 
galactaric acid catabolism in E. coli and A. tumefaciens is the conversion of galactarate to 
3-deoxy-2-keto-hexarate by galactarate dehydrogenase. (Groninger-Poe et al., 2014; 
Richard and Hilditch, 2009) Then the pathways differ, and in E. coli (Figure 6) 2-dehydro-
2-deoxyglucarate aldolase splits 3-deoxy-2-keto-L-threo-hexarate to pyruvate and 
L-tartonate semialdehyde. In the following step, L-tartonate semialdehyde is reduced to 
D-glycerate by 2-hydroxy-3-oxopropionate reductase. (Richard and Hilditch, 2009) 
 
 
Figure 6 Galacturonic acid catabolic pathway in Escherichia coli (Richard and Hilditch, 
2009). In this pathway, galactaric acid is converted to pyruvate and D-glycerate in three 
steps.  
5 Genetic engineering of Aspergillus niger 
Traditionally, strain improvements have been done using classical methods: random 
mutagenesis and screening. Nowadays, tools for genetic modifications have been 
developed, enabling more targeted gene modification and metabolic engineering. (Knuf 
and Nielsen, 2012) Methods and tools covered in this chapter are homologous 
recombination, CRISPR/Cas9 and TALENs.  
Aspergilli host systems offer an alternative to E. coli and yeasts. They can perform post-
translational modifications efficiently and express heterologous eukaryotic proteins in a 
correctly folded form. (Ward et al., 2005) For example, A. niger can be a suitable host for 
heterologous protein expression (Punt et al., 2002; Schuster et al., 2002). On the other 
hand, transferring DNA into Aspergilli is extremely inefficient compared to E. coli and 
yeasts. Natural plasmids able to serve as a vector backbone for Aspergilli have not been 
 16 
 
discovered. Therefore, expression vectors for recombinant protein are usually 
integrated into the chromosomal DNA and screened using different selection markers. 
(Fleißner and Dersch, 2010)  
There are different transformation methods for introducing genes to Aspergilli: 
protoplast method, electroporation, Agrobacterium transformation and biolistic 
methods. Protoplast method is an efficient way and the most routinely used method to 
transform A. niger. In the protoplast transformation, the protoplasts are obtained by 
enzymatically digesting cell walls of germinated conidia or young mycelia. The 
protoplasts are incubated with plasmid DNA, polyethylene glycol (PEG) and in osmotic 
medium containing CaCl2 and then spread on a selective solid medium. PEG is 
indispensable for transformation, because it helps the DNA to enter the cell. (Lakshmi 
Prabha and Punekar, 2004; Kawai et al., 2010; Meyer et al., 2011) Electroporation and 
biolistic methods are less efficient than the protoplast method. Using Agrobacterium 
transformation high numbers of transformants have been obtained. (Fleißner and 
Dersch, 2010) 
5.1 Homologous recombination 
In homologous recombination, nucleotide sequences are exchanged between similar 
DNA molecules. It is a repair mechanism in eukaryotes used to repair double-strand 
breaks (DSBs) (Dudášová et al., 2004). Homologous recombination is a commonly used 
method in the genetic engineering of fungi. For example, genes of A. niger can be 
deleted from the genome by replacing the target gene with a constructed deletion 
cassette (Figure 7). The deletion cassette consists of two flanking regions homologous to 
the sequences upstream and downstream of the target gene and, for example, a 
selection marker between these flanking regions.  
 
 17 
 
 
Figure 7 Gene deletion by homologous recombination in A. niger. (A) is part of the 
genome where the target gene is located. (B) is a deletion cassette designed for the 
target gene. When the deletion cassette is transformed to the cell, the cassette will 
replace the target gene and the gene is deleted forming (C). 
 
There is a diverse selection of markers available for A. niger (Table 1): antibiotic 
resistance markers (hph, oliC, bar), auxotrophic markers (pyrG, argB, niaD, trpC, sC), and 
nutrional markers (amdS, agaA). From the above mentioned markers pyrG, niaD, sC and 
amdS are also counter selectable markers. (Lakshmi Prabha and Punekar, 2004; Meyer 
et al., 2011; Dave et al., 2012; Lenouvel et al., 2002) Counter selection enables selection 
of both the presence and the absence of the marker. For example, pyrG+ cells (cells 
harboring the pyrG gene) are able to grow in media lacking uracil or uridine, whereas 
pyrG- cells (cells without the pyrG gene) cannot grow in the same media. On the other 
hand, pyrG+ cannot grow in media containing 5-fluoro-orotic acid (5-FOA), because it 
decarboxylates 5-FOA to toxic 5-fluorouracil. pyrG- does not have the ability to convert 
5-FOA, hence it can grow in media containing 5-FOA. After the cassette has been 
constructed, it is transformed into A. niger and the gene of interest is deleted by 
homologous recombination. Using the same method, genes can also be integrated into 
the genome. 
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Table 1 Selection markers available for A. niger (Lakshmi Prabha and Punekar, 2004; 
Dave et al., 2012). 
Selection marker Encoded function Selection 
hph Hygromycin B 
phosphotransferase 
Hygromycin resistance 
oliC Oligomycin-resistant 
mitochondrial ATP synthase 
Oligomycin resistance 
bar Phosphinothricin acetyl 
transferase 
Phosphinothricin resistance 
pyrG Orotidine-5'- phosphate 
decarboxylas 
Uridine/uracil prototrophy, 
 5-fluoro-orotic acid resistance 
argB Ornithine carbamyltransferase Arginine prototrophy 
niaD Nitrate reductase Nitrate utilization,  
Chlorate resistance 
trpC Trifunctional enzyme of 
tryptophan biosynthesis 
Tryptophan prototrophy 
sC ATP sulfurylase Sulfate utilization, 
Selenate resistance 
amdS Acetamidase Acetamide utilization, 
Fluoroacetamide resistance 
agaA Arginase Arginine protoyrophy 
 
The gene targeting frequencies in A. niger, and generally in filamentous fungi, are often 
extremely low compared to S. cerevisiae (Carvalho et al., 2010). The cassette usually 
integrates randomly into the genome instead of the desired place, due to the non-
homologous end joining pathway (NHEJ). NHEJ is the dominant DNA DSB repair 
mechanism in filamentous fungi compared to the homologous recombination pathway 
(HR). Deleting kusA, which encodes one of the proteins involved in NHEJ, improves 
homologous recombination. However, the strain is genetically unstable due to the 
increased sensitivity towards DNA damages caused by X-ray irradiation and UV 
exposure. (Meyer et al., 2007) In addition, Meyer et al. (2007) have shown that the 
lengths of the flanks in the cassette affect the homologous recombination frequency. 
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With 1500 bp flanks, the homologous recombination frequency of A. niger ΔpyrGΔkusA 
strain was as high as 98 %. Shorter flanks resulted in a notably lower frequency. 
There is only a limited amount of selection markers available and therefore it would be 
advantageous to delete genes without leaving a marker on the genome. Delmas et al. 
(2014) have presented a method in which selection markers can be recycled for deleting 
genes in filamentous fungi. In this method, a plasmid with a selection marker is 
integrated to the genome and later excised. The method was demonstrated using 
filamentous fungi A. niger and Talaeomyces versatilis by deleting gene xlnR encoding 
xylanolytic transcriptional regulator. The plasmids used for recombination were non-
replicative and harboured pyrG gene and flanking regions. When the plasmid was 
integrated to the genome and the xInR gene was deleted, the cells were grown on a 
medium containing uridine to release the selective pressure for plasmid integration, 
resulting in the excision of the plasmid and the recovery of the pyrG selection marker. 
The excision using homology of the flanking region can lead to reversal to the wild-type 
locus or deletion of the target gene. The ΔpyrG strain was selected by plating to a 
medium containing uridine and 5-fluoro-orotic acid. Other available methods to perform 
deletions without leaving a selection marker on the genome are CRISPR/Cas9 (see 5.2) 
and TALENS (see 5.3). 
Deleting an essential gene might result in formation of heterokaryons in primary 
transformants. Heterokaryon is a cell which has more than one nucleus and the nuclei 
are genetically different. Heterokaryotic strains are able to grow on selective conditions, 
but the two types of conidia produced from the heterokaryotic mycelium will not 
germinate on a selective medium. The conidia with untransformed nuclei will not grow 
because they lack the selection marker and the conidia with transformed nuclei will not 
grow due to the deletion of an essential gene. However, subculturing mycelia fragments 
is still possible. (Meyer et al., 2007) Thus, if the deleted gene is essential for the survival 
of the cell, it would be difficult to obtain a pure culture. Southern blot analysis could be 
used for verifying heterokaryotic strains (Meyer et al., 2007).  
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5.2 CRISPR/Cas9 system 
Clustered regularly interspaced short palindromic repeats (CRISPR) is a bacterial and 
archaeal adaptive immune mechanism against foreign DNA derived from, for example, 
bacteriophages, plasmids and viruses. (Sander and Joung, 2014; Hsu et al., 2014) CRISPR 
array contains short partially palindromic DNA repeats called CRISPR repeats that occur 
at regular intervals alternating with variable sequences called CRISPR spacers. The 
immune mechanism has three steps: adaption, CRISPR RNA (crRNA) biogenesis and 
targeting. In the adaption step, certain CRISPR-associated enzymes (Cas) acquire short 
exogenous DNA fragments which are inserted into the CIRSPR array as new spacers. 
Next, in crRNA biogenesis, CRISPR arrays are transcribed and processed into crRNAs. 
Biogenesis and processing of crRNA is unique for each CRISPR type. Finally, in the 
targeting step, crRNAs guide Cas nucleases for specific cleavage of homologous 
sequences and degrade the foreign DNA. (Barrangou and Marraffini, 2014; Hsu et al., 
2014)  
There are three types of CRISPR system in which CRISPR/Cas9 is a type II CRISPR system. 
In the biogenesis of crRNA in type II CRISPR, a transactivating CRISPR RNA (tracrRNA) 
hybridized with CRISPR repeats forming a RNA duplex that is cleaved by endogenous 
RNase III liberating small crRNAs. The crRNA are further trimmed at their 5’ end by an 
unknown nuclease. Cleavage of the DNA in type II CRISPR is carried out by endonuclease 
Cas9 guided by guide RNA (gRNA). Cas9 has two independent nuclease domains, HNH 
and RuvC, which both cleave one strand of the target DNA generating a blunt-ended 
DSB. (Barrangou and Marraffini, 2014; Hsu et al., 2014) 
In genome editing, Cas9 guided by synthetic gRNA creates a specific DNA DSB to the 
target site in the genome (Figure 8). The Cas9 used in the CRISPR/Cas9 genome editing is 
most commonly derived from Streptococcus pyogenes (Nødvig et al., 2015), but Cas9 
derived from Streptococcus thermophilus is also available (Hsu et al., 2014). Recently a 
commonly used gRNA type is single gRNA, which is a fusion of crRNA and tracrRNA. 
Another available type of gRNA is the dual gRNA, in which crRNA and tracrRNA are 
expressed separately.  In general, the results have been better with single gRNA than 
with dual gRNA. (Sander and Joung, 2014) The crRNA consist of a protospacer and 
CRISPR repeats. The protospacer consists of 20 nucleotides, which recognize the target 
site by base pairing. (Sander and Joung, 2014; Hsu et al., 2014; Nødvig et al., 2015) The 
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Cas9 and the gRNA can be expressed in the same vector in vivo (Nødvig et al., 2015), but 
the gRNA can also be synthetized in vitro (Liu R. et al., 2015).  
 
 
Figure 8 CRISPR/Cas9 system. The Cas9 endonuclease is guided by synthetic single 
guideRNA (gRNA) to the target site in the genome based on the protospacer sequence in 
the gRNA and protospacer adjacent motif (PAM) in the genome. Then Cas9 cleaves the 
DNA from 3-5 bp upstream of the PAM generating a double-stranded break (DSB). 
 
Besides Cas9 and gRNA, the system also requires protospacer adjacent motif (PAM) to 
work efficiently. PAM is a three nucleotide sequence, which is adjacent to the binding 
site of gRNA in the downstream of the target site. Cas9 will cleave from the target site at 
3-5 bp upstream of the PAM. For the Cas9 derived from S. pyrogenes the PAM sequence 
is NGG. There is also a less efficient alternative PAM sequence, NAG. (Sander and Joung, 
2014; Nødvig et al., 2015)  
Cas9 can also be modified to expand its functionality. By inactivating the HNH or the 
RuvC nuclease domains of the Cas9 via point mutations, Cas9 can be modified to create 
single stranded break (SSB). These Cas9 nickases can be exploited for more specific NHEJ 
and HR, because SSBs are repaired by the high-fidelity base excision repair. Using a Cas9 
nickase with two gRNAs and appropriately spaced target sites can mimic DSBs and 
mediate efficient indel formation. (Hsu et al., 2014) A catalytically dead Cas9 (dCas9) can 
be utilized in controlling gene expression. dCas9 has mutations in both HNH and RuvC 
domains. It is a RNA guided DNA binding protein, which can be used to repress or 
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activate genes. Genes can be repressed by directing dCas9 to a promoter sequence 
interfering transcription initiation or to the template strand within an ORF blocking 
transcription elongation. Activation of genes can be done by fusing the dCas9 with 
different functional domains, for example, transcriptional activators and reporters to 
specific sites of the genome. In addition to altering the transcription states, chromatin 
states can also be monitored and even the three-dimensional organization of the 
genome can be rearranged. (Barrangou and Marraffini, 2014; Hsu et al., 2014) 
Recently, CRISPR/Cas9 technology has developed rapidly and become a new powerful 
tool in genome editing because it is very simple and easy to use. With the CRISPR/Cas9 
technology it is possible to introduce multiple targeted DSBs to DNA triggering NHEJ 
pathways or HR to repair DSBs, and even insert a desired sequence to the targeted site. 
(Sander and Joung, 2014; Hsu et al., 2014; Nødvig et al., 2015) NHEJ-mediated repair can 
result in variable length of indels at the DSB site. Genes can be inserted to the DSB site 
by using a donor DNA to trigger homologous recombination. (Sander and Joung, 2014; 
Hsu et al., 2014) Using the CRISPR/Cas9 system, gene deletion can be done without 
leaving a selection marker or foreign DNA in the genome. 
CRISPR/Cas9 system has been used to engineer bacteria, yeasts, mammalian cells (eg. 
mice, rats, rabbits and human cells), insects, worms, fish and plants (eg. rice and wheat). 
(Sander and Joung, 2014; Nødvig et al., 2015) In the case of filamentous fungi, 
A. fumigatus (Fuller et al., 2015), A. aculeatus, A. niger, A. nidulans, A. carbonarius, 
A. luchuensis, A. brasiliensis (Nødvig et al., 2015), A. oryzae (Katayama et al., 2015), 
T. reesei (Liu R. et al., 2015) and Pyricularia oryzae (Arazoe et al., 2015b) have been 
engineered successfully utilizing the CRISPR/Cas9. As a genome editing tool, 
CRISPR/Cas9 system is more efficient and precise at targeting genes than merely using 
homologous recombination. 
5.3 TALENs 
Similar to the CRISPR/Cas9 system, transcription activator-like effector nucleases 
(TALENs) induce DNA DSBs at the target site that will trigger NHEJ or HR (Ochiai and 
Yamamoto, 2015). In addition, two TALEN pairs can also be used to delete or inverse 
large chromosomal segments by targeting to the same chromosome (Joung and Sander, 
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2013). TALENs are artificial fusion proteins composed of a customizable DNA binding 
domain fused to a nonspecific nuclease domain from the FokI restriction enzyme (Figure 
9). The whole TALEN consists of N-terminal domain, TALE repeat domains, C-terminal 
domain and FokI nuclease domain. Two TALENs are needed to bind to the target site as 
a dimer for cleaving the DNA. (Joung and Sander, 2013) FokI is a type IIS restriction 
enzyme, which cleaves DNA at a defined distance away from their recognition sites. The 
TALENs bind to the target sites of DNA separated by spacer sequence (13-33 bp) facing 
one another and introduce DSB to the spacer. (Ochiai and Yamamoto, 2015) 
 
 
Figure 9 Transcription activator-like effector nuclease (TALEN) consists of DNA binding 
domain and an unspecific FokI endonuclease domain. N- and C-terminal domain and 
TALE repeat domains between terminal domains form the DNA binding domain. Each 
TALE repeats consists of 33-35 amino acid repeats, which have repeat variable di-
residues (RVDs) at position 12 and 13. RVDs are responsible of recognizing the target 
sequence and binding to it. Two TALENs are needed for the cleavage of the DNA. The 
cleavage site is in the spacer region between the target sequences. 
 
TALE repeat domains are composed of multiple nearly identical repeats (7-30) derived 
from transcription activator-like effectors (TALEs), which are proteins secreted by 
Xanthomonas spp. bacteria plant pathogen. These TALE repeats consists of 33-35 amino 
acid repeats. TALE repeat domains form an array that bind to single bases in the target 
sequence according to the repeat variable di-residues (RVDs) typically found at positions 
12 and 13. RVDs are highly variable among the repeat unit and each RVDs NN, NI, HD 
and NG recognized DNA bases guanine, adenine, cytosine and thymine, respectively. 
There are also other more specific RVD for the DNA bases, but TALE repeat array using 
these RVDs show lower activity. The target sequence of TALENs begin with thymine, 
because the N-terminal domain recognizes the thymine adjacent to the nucleotide 
sequence recognized by the TALE repeat domains. TALENS also harbour non-repeat 
variable di-residue (non-RVD) at position 4 and 32, known as Platinum TALENS, which 
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have higher activity than TALENs without non-RVD variations. TALEs can be designed to 
bind to the specific target sequence by simply joining appropriate repeat units. (Joung 
and Sander, 2013; Ochiai and Yamamoto, 2015; Arazoe et al. 2015a) Truncation of the 
N- and C-terminal domains affect the DSB-introducing activities of TALENs. TALENs with 
N-terminal domain of +136 and C-terminal domain of +63 are the most commonly used 
and are highly active. (Ochiai and Yamamoto, 2015) 
TALENs have been utilized in engineering for example, yeast, cricket, silkworm, fruitfly, 
zebrafish, plant Arabidopsis thaliana cows, pigs and human somatic and pluripotent 
stem cells (Joung and Sander, 2013). The only publication I found about engineering 
filamentous fungi with TALENs was reported by Arazoe et al.  (2015a) in which they 
demonstrated TALEN-based genome editing via HR repair in filamentous fungus 
Pyricularia oryzae using Platinum-Fungal TALENs (PtFg TALENs). Arazoe et al. concluded 
that PtFg TALENs could improve the efficiency of targeted gene replacement by 
homologous recombination by up to 100%.  
TALENs technology was introduced before the CRISPR/Cas technology. It seems to have 
higher specificity than CRISPR/Cas, but the preparation for genome editing of 
CRISPR/Cas is easier (Ochiai and Yamamoto, 2015) which makes the CRISPR/Cas the 
more preferable choice for genome editing. 
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EXPERIMENTAL STUDY 
6 Materials and Methods 
6.1 Microbial strains and media 
A. niger, S. cerevisiae and E. coli strains used or constructed in this study are listed in 
Table 2. Gene pyrG encoding orotidine-5'- phosphate decarboxylase was used as a 
selection marker in all gene deletions of A. niger. S. cerevisiae ATCC 90845 was used for 
homologous recombination when constructing deletion cassettes and CEN.PK2-1D for 
expressing the open reading frame (ORF) of genes. E. coli TOP 10 was used for plasmid 
production. Liquid media and plates used in this study are listed in Table 3. 
E. coli was cultivated in 5 ml Luria Broth (LB) medium with 100 µg/ml ampicillin for 
minipreps. A. niger cultivations for preparing protoplasts needed in transformation were 
performed in yeast Peptone medium with 3 % gelatin (YP-G). Mineral medium with 10 
g/l galactaric acid (MM-McA), mineral medium with 10 g/l galactaric acid and 0.5 % 
xylose (MM-XMcA), yeast peptone medium with 10 g/l galactaric acid (YP-McA) and 
yeast peptone medium with 10 g/l D-glucaric acid (YP-GlcA) were used to examine the 
galactaric acid and glucaric acid consumption of the constructed mutant strains. Mineral 
medium with 20 g/l D-galacturonic acid (MM-GalA), mineral medium with 20 g/l 
D-galacturonic acid and 0.5 % xylose (MM-XGalA) and yeast peptone medium with 20 g/l 
D-galacturonic acid (YP-GalA) with pH 5 and 3 were used to investigate the production of 
galactaric acid of galactaric acid producing A. niger ΔgaaA udh Δ39114 strain. 
SCD-URA plates were used for screening A. niger and S. cerevisiae transformants. 
A. niger spores were produced on potato dextrose (PD) agar plates (incubation at 28 °C, 
4-5 days) and collected with 2-4 ml spore stock solution (20% glycerol, 0.8% NaCl and 
0.025 Tween 20) as suspension. Spores were filtered through a pipet tip with cotton 
wool. 
S. cerevisiae was grown on YP plates. YPD medium was used to cultivate S. cerevisiae for 
transformation. For expressing ORFs and testing enzyme activities using enzyme activity 
assay, S. cerevisiae was cultivated in Y-min medium with SC-URA and 2 % glucose. 
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Table 2 Microbial strains used in this study. Gene pyrG encodes orotidine-5'- phosphate 
decarboxylase, kusA is a gene responsible for non-homologous end joining, gaaA 
encodes D-galacturonic acid reductase, gaaC encodes 2-keto-3-deoxy-L-galactonate 
aldolase and udh encodes D-galacturonate dehydrogenase. 
Name Parental 
strain 
Genetic modifications Reference 
Aspergillus niger   
Wild type, ATCC 1015   Andersen et 
al., 2011 
ΔpyrG ATCC 1015 Deletion of pyrG gene Kuivanen et 
al., 2012 
ΔpyrGΔkusA ΔpyrG Deletion of pyrG and kusA Unpublished 
Δ39114 ΔpyrG Deletion of gene 39114 This study 
Δ1090836 ΔpyrG Deletion of gene 1090836 This study 
Δ1117792 ΔpyrG Deletion of gene 1117792 This study 
Δ1141260 ΔpyrG Deletion of gene 1141260 This study 
Δ1121140 ΔpyrG Deletion of gene 1121140 This study 
Δ1162477 ΔpyrG Deletion of gene 1162477 This study 
Δ1146483 ΔpyrG Deletion of gene 1146483 This study 
Δ1170646 ΔpyrG Deletion of gene 1170646 This study 
Δ39114ΔgaaA/C::udh Δ39114 Deletion of gaaA and gaaC and 
integration of  udh derived from P. 
syringae to gaa/C locus 
This study 
Δ39114ΔgaaA/C Δ39114 Double deletion of gaaA and gaaC This study 
Δ39114ΔgaaA/C udh Δ39114 
ΔgaaA/C 
Double deletion of gaaA and gaaC 
and random integration of  udh 
derived from P. syringae 
This study 
ΔgaaA udh  Deletion of gaaA and integration of 
codon-optimized udh derived from 
A. tumefaciens 
Mojzita et al., 
2010 
ΔgaaA udh Δ39114 ΔgaaA udh Deletion of gene 39114 from ΔgaaA 
udh 
This study 
Saccharomyces cerevisiae   
ATCC 90845    
CEN.PK2-1D   Expression of ORF of A. niger gene  
SC39114 CEN.PK2-1D Expression of the ORF 39114 with 
pE39114 expression plasmid 
This study 
SC1090836 CEN.PK2-1D Expression of the ORF 1090836 
with pE39114 expression plasmid 
This study 
SC1121140 CEN.PK2-1D Expression of the ORF 1121140 
with pE39114 expression plasmid 
This study 
Escherichia coli   
TOP 10  Used for plasmid production  
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Table 3 List of liquid media and plates used in this study for cultivation. ORF = open 
reading frame 
Media Abbreviation Usage 
Luria Broth LB E. coli cultivation 
Yeast Peptone medium with 3 % gelatin, 
pH 7 
YP-G A. niger precultivation 
Mineral medium with 1% galactaric acid, 
pH 7 
MM-McA A. niger cultivation with 
galactaric acid 
Mineral medium with 1% galactaric acid 
and 0.5 % xylose, pH7 
MM-XMcA A. niger cultivation with 
galactaric acid 
Yeast Peptone medium with 1% 
galactaric acid, pH 7 
YP-McA A. niger cultivation with 
galactaric acid 
Yeast Peptone medium with 1% D-
glucaric acid, pH 7 
YP-GlcA A. niger cultivation with 
glucaric acid 
Mineral medium with 2% galacturonic 
acid, pH 5 or pH 3 
MM-GalA A. niger cultivation with 
galacturonic acid 
Mineral medium with 2% galacturonic 
acid and 0.5 % xylose, pH 5 
MM-XGalA A. niger cultivation with 
galacturonic acid 
Yeast Peptone medium with 2% 
galacturonic acid, pH 5 or pH 3 
YP-GalA A. niger cultivation with 
galacturonic acid 
A. Nidulans defined minimal medium   A. niger cultivation with 
citrus processing waste 
Yeast Peptone medium with 2% glucose YPD S. cerevisiae cultivation 
Yeast nitrogen base without amino acids Y-min S. cerevisiae cultivation for 
ORF expression 
Agar plates Abbreviation Usage 
SCD-URA transformation plate  A. niger transformation 
using homologous 
recombination 
Transformation plate with 400 µg/ml 
hygromycin (minimal medium) 
 A. niger transformation 
using CRISPR/Cas9 system 
Synthetic complete medium without 
uracil containing 2 % glucose  
SCD-URA A. niger screening, S. 
cerevisiae 
Synthetic complete medium without 
uracil containing 2 % D-galacturonic acid 
SCGalA-URA Verifying the deletions of 
gaaA and gaaC in A. niger 
Potato dextrose agar PD A. niger spore germination 
Yeast Peptone YP S. cerevisiae 
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6.2 Deletion of potential genes in galactaric acid pathway 
6.2.1 Construction of deletion cassette 
First, the plasmids containing deletion cassette were constructed. The cassette consisted 
of two flanking regions amplified from A. niger ATCC 1015 genome, an auxotrophic 
selection marker pyrG and a backbone plasmid. The deletion cassettes were designed to 
have a NotI restriction site in order to digest the cassette, which consist of flanking 
regions and the pyrG, from the plasmid. Flanking regions (1.5 kb) were amplified from 
the genomic DNA up- and downstream of the gene of interest. Geneious ver. 8.1.7 
(Biomatters Ltd.) was used to design primers. The primers used for amplifying the 
flanking regions are listed in Appendix 1 Table 1. The backbone plasmid p2974 (pRS426, 
Colot et al., 2006) linearized with EcoRI and BamHI has ampicillin as E. coli selection 
marker, bacteria origin of replicon ori, URA3 gene as S. cerevisiae selection marker and 
yeast origin of replicon 2µ. Then S. cerevisiae was transformed using Gietz protocol with 
(see 6.6.1) all these four fragments (two flanking regions, pyrG gene and the backbone 
plasmid) for homologous recombination using Gietz protocol  to assemble the plasmid. 
Cells were plated on SCD-URA plates and incubated at 30 °C for 4 days. 
Next, the grown S. cerevisiae transformants were collected from the plate and the 
plasmids were rescued from the transformants with a miniprep (QIAprep Spin Miniprep 
Kit). Then E. coli was transformed by electroporation with the plasmids and grown on LB 
plates containing ampicillin (100 µg/ml) at 37 °C overnight (electroporation protocol see 
6.6.2). Colony PCR was performed to confirm that the E. coli transformants harboured 
the desired plasmid. The plasmids were then isolated from the confirmed E. coli colony. 
Finally, the plasmids were verified by the digestion with NotI and the sequencing of the 
5’ flanking region. The sequencing primer attached to the beginning of the pyrG gene 
and sequenced in the reverse direction. 
6.2.2 Targeted deletion 
The cassettes were digested with NotI from the plasmids containing the cassette and the 
solution containing the cassette was concentrated by ethanol precipitation, in which 
1000 µl absolute ethanol and 40 µl 3 M sodium acetate were mixed with 300 µl cassette 
solution and incubated at -20 °C for 20 min. Then the mixture was centrifuged at 4 °C for 
10 min at full speed. The DNA pellet was washed with 300 µl 70 % ethanol and 
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centrifuged at room temperature for 5 min at full speed. The pellet was dried and 
resuspended in 100 µl transformation buffer.  
Deletion was performed by homologous recombination in A. niger by transforming the 
ΔpyrG (orotidine-5'- phosphate decarboxylase deletion strain) and ΔpyrGΔkusA strains 
(orotidine-5'- phosphate decarboxylase and NHEJ deletion strain) with the cassettes 
(transformation see 6.6.3). Deletion was also performed using the CRISPR/Cas9 method, 
in which the ΔpyrG strain was transformed with the pFC-332 plasmid harboring Cas9 
(Nødvig et al., 2015), two single gRNAs and a donor DNA. The gRNAs were designed to 
guide Cas9 to cleave DNA both upstream and downstream of the gene to be deleted. GC 
content of the target sites were designed to be at least 40 %. The gRNAs were 
synthesized in vitro using GeneArtTM Precision gRNA Synthesis Kit (ThermoFisher 
Scientific). The oligonucleotides needed for the synthesis of gRNA are listed in Appendix 
1 Table 5. The constructed deletions cassettes were used as donor DNA for the 
selection. Around 10 µg of gRNAs and deletion cassette and 1 µg of pFC-332 was used in 
transformation, except for deleting 1146483 only 5 µg of deletion cassette was used.  
Transformants were screened by colony PCR using Phire Plant Direct PCR Kit (Thermo 
Scientific).  The 5’ flanking region was amplified with primers annealing to the beginning 
of the pyrG gene and outside of the 5’ flanking region, the 3’ flanking region with 
primers annealing to the end of the pyrG gene and outside of the 3’ flanking region and 
part of the ORF was amplified  with primers annealing internal to the gene of interest. 
The colonies were also screened by colony PCR using primers binding outside of the 5’ 
flanking region and inside the ORF. The primers are listed in Appendix 1 Table 2. The 
screened colonies were also inoculated to SCD-URA masterplate (incubation 28 °C, 2 
days) for further purification.  
Colonies in which deletion had occurred were purified by single spore isolation. First, the 
colonies were inoculated from the SCD-URA masterplate to PD plate for sporulation 
(incubation 28 °C, 2 days). Then the spores were collected, mixed to spore stock solution 
and diluted 10, 100 and 1000 times with spore stock solution. 10 µl of diluted 
suspensions were plated to SCD-URA plate (incubation 28 °C, 2 days). Colonies on the 
SCD-URA plates were screened by colony PCR again and inoculated to PD plate. The 
strains went through single spores until a pure culture was obtained. Pure cultures were 
let to sporulate on PD plate, the spores were collected, and spore stocks were prepared. 
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Pure gluconokinase 1162477 mutants were also cultivated on 2 % gluconic acid plates as 
a screening method.  
6.3 Identification and characterization of the proteins 
6.3.1 Cultivation of deletion mutants with hexaric acid 
The mutant strains were precultivated by inoculating 300-400 µl spores into 50 ml YP-G 
medium and incubating at 28 °C for 21 hours. Then the grown mycelia were collected by 
filtering through a sterile Glass Microfibre Filter (55mm diameter, Whatman, GE 
Healthcare Life Science, USA) with vacuum and washed with sterile water. The mycelia 
were resuspended in the MM-McA or YP-GlcA medium. Cultivation was done in 24 wells 
plates with two replicates. Around 0.02 g wet cells mass (in 0.5 ml MM-McA) of the 
mycelia were inoculated into 3.5 ml of MM-McA, MM-XMcA and YP-McA or YP-GlcA 
medium (Table 3), hence the initial biomass concentration was 5 g wet cell mass/l. 
Cultures were incubated at 28 °C, 800 rpm for 5 days. Samples of 0.5 ml were taken at 
24 h, 48 h and 120 h and filtered with 24 wells 10 µm Melt Blown Polypro Filter 
(Whatman, GE Healthcare) or 96 well MultiScreen HTS DV Filter Plate (0.65 µm 
Hydrophilic Low Protein Binding, Durapore® Membrane). 
6.3.2 HPLC analysis 
The consumption of galactaric acid was analyzed with high performance liquid 
chromatography (HPLC) using a Animex Fast Acid column (100 mm by 7.8 mm, Bio-Rad 
Laboratories) linked to Animex HPX-87H organic acid analysis column (300 mm by 
7.8 mm, Bio-Rad Laboratories). The columns were maintained at 55 °C and 5 mM H2SO4 
was used as an eluent with flow rate 0.5 ml/min. Waters 2489 UV/Visible dual-
wavelength UV (210 nm) detector was used for detection. 
6.3.3 Expressing genes in Saccharomyces cerevisiae  
First, the cDNA was generated to amplify the ORFs of the genes of interest for 
expression plasmid construction. The wild-type A. niger ATCC 1015 strain was cultivated 
in YP medium with 3% gelatin, collected and frozen in liquid nitrogen. Then total RNA 
was extracted using RNeasy Plant Mini Kit (Qiagen) and genomic DNA was removed 
using DNase I following Removal of Genomic DNA from RNA Preparations protocol 
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(Thermo Scientific). The cDNA was synthetized using Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche) and the ORF was amplified using cDNA as the template. EcoRI 
restriction site and Kozak sequence were added upstream and BamHI restrictrion site 
downstream of the ORF. The primers for amplifying the ORFs are listed in Appendix 1 
Table 3. The PCR product of the ORF was purified with a Miniprep column (Qiagen), 
digested with EcoRI and BamHI and purified by gel extraction. Then the ORF was ligated 
with the linearized expression vector p2159 by T4 ligase, and introduced into E. coli. The 
expression vector p2159 was derived from pYX212 (R&D systems) by modifying the 
multiple cloning site (Verho et al., 2004) and digesting with EcoRI and BamHI. The whole 
ORF was sequenced. Sequencing primers are listed in Appendix 1 Table 3. Then the 
expression plasmids were transformed into S. cerevisiae CEN.PK-1D and the 
transformants were grown on SCD-URA plates. Two transformants were inoculated from 
the transformation plate to new SCD-URA plate to prepare glycerol stocks for further 
experiments.  
6.3.4 Enzyme Assay 
Crude extract for the enzyme assay was prepared by cultivating S. cerevisiae CEN.PK2-1D 
harbouring a gene expression plasmid in Y-min medium containing SC-URA and 2 % 
glucose at 30 °C, 250 rpm for overnight. The cells of overnight culture were collected (4 
°C, 5000 rpm, 5 min), washed with cold sterile water and pelleted (4 °C, 5000 rpm, 5 
min). The pellet was resuspended in 1 ml lysis buffer (0.1 M NaPO4 containing complete 
protease inhibitor). The cells were broken with glass beads (diameter 0.5 mm) using the 
Precellys 24 (Bertin Technologies) for three times 30 s. The mixture was centrifuged (4 
°C, 14 000 rpm, 20 min) and the supernatant also known as the crude extract was 
collected. 
In the assay, galactaric acid was used as the substrate and the formation or consumption 
of NAD(P)H was followed at 340 nm using a spectrophotometer for 300 s with readings 
in 10 s interval. The 1 ml reaction mix contained NaPO4 buffer (50 mM, pH 7), ATP (0.5 
mM), MgCl2 (1mM), galactaric acid (2mM), a cofactor (NADH or NADPH 0.2 mM, or NAD 
or NADP 0.5 mM), 10 µl crude extract. The activity of the 39114 enzyme was also tested 
using 10 mM glucaric acid as the substrate and NADH and NADPH as cofactors.  
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6.4 Construction of galactaric acid producing A. niger strains 
6.4.1 Construction of the Δ39114ΔgaaA/C::udh and Δ39114ΔgaaA/C udh 
strains 
The plasmid containing integration cassette for deleting the genes gaaA and gaaC 
(gaaA/C) and expressing udh in the Δ39114 strain was designed to contain two flanking 
regions, gpdA promoter, udh, trpC terminator and hph coding regions and to be released 
from the plasmid with NotI. The used backbone plasmid p2974 had ampicillin resistance 
gene as E. coli selection marker, bacteria origin of replicon ori, URA3 gene as the 
S. cerevisiae selection marker and yeast origin of replicon 2µ.  
Flanking regions were amplified from genomic DNA using primers oPEEL-053-oPEEL-056 
(Appendix 1 Table 4). The gene udh with promoter, terminator and hph were amplified 
from the plasmid p6042 using primers oPEEL-051 and oPEEL-052 (Appendix 1 Table 4). 
Three different methods were used to assemble the fragments of the plasmid containing 
the integration cassette: homologous recombination in S. cerevisiae, Gibson Assembly 
and TOPO Cloning. In yeast homologous recombination the S. cerevisiae ATCC 90845 
was transformed with the fragments. Then the resulting plasmid was rescued from the 
yeast and E. coli was transformed with the rescued plasmid by electroporation. In 
Gibson Assembly, Gibson Assembly Cloning Kit (BioLabs) was used to assemble the 
integration cassette. The fragments were assembled with the reaction mix provided by 
the kit and then E. coli was transformed with the plasmid by electroporation. In TOPO 
Cloning, the integration cassette was amplified as one fragment in one PCR reaction 
(Kapa HiFi PCR Kit) using previously amplified flanking regions and udh as the templates 
and oPEEL-053 and oPEEL-056 as the primers. The cassette was then purified by gel 
extraction and ligated with TOPO vector using Zero Blunt TOPO PCR Cloning Kit. Then 
E. coli was transformed with the ligated plasmid by electroporation for plasmid 
production. The E. coli transformants harboring the plasmids assembled using different 
methods were screened by colony PCR by amplifying the 5’ and 3’ flanking regions of the 
plasmid. The plasmid assembled using yeast homologous recombination was also 
digested with NotI. 
The CRISPR/Cas9 method was also used to delete the gaaA/C gene from the Δ39114 
strain and integrate the udh gene into the same strain. Two gRNAs were designed to 
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guide Cas9 to cleave DNA at the gaaA and gaaC locus. The gRNAs were synthesized in 
vitro using GeneArtTM Precision gRNA Synthesis Kit and the oligonucleotides oPEEL-080 – 
oPEEL-083 (Appendix 1 Table 4). The gpdA-udh fragment (2.5 kb) used as a donor DNA, 
containing the gpdA promoter and the udh gene, was amplified using the plasmid p6042 
as the template (Kapa HiFi PCR Kit). The primers oPEEL-084 and oPEEL-085 (Appendix 1 
Table 4) used for the amplification were 80 bp long from which 60 bp was homologous 
to the genome. After all the different components needed for CRISPR/Cas9 were 
prepared, they were transformed into the Δ39114 strain. Three different 
transformations were performed: 1) the Δ39114 strain transformed with pFC-332 (as a 
control), 2) the Δ39114 strain transformed with pFC-332 and two gRNAs and 3) the 
Δ39114 strain transformed with pFC-332, two gRNAs and the gpdA-udh fragment. The 
transformation was performed with around 10 µg of gRNAs, 10 µg of donor DNA and 
1 µg of the pFC-332 plasmid. The correct colonies were identified by colony PCR using 
primers oPEEL-086 and oPEEL-087 (Appendix 1 Table 4), which bind to the outside of the 
gaaA/C gene. Selection of the Δ39114ΔgaaA/C strain was also performed by cultivating 
on SC-URA plate with 2 % D-galacturonic acid (28 °C, 2 days). The Δ39114 strain was 
used as a control strain. 
6.4.2 Construction of the ΔgaaA udh Δ39114 strain 
The 39114 gene was deleted from A. niger ΔgaaA udh strain (Mojzita et al., 2010) using 
the CRISPR/Cas9 method. In the ΔgaaA udh strain, the pyrG gene was used as a 
selection marker in the gaaA gene deletion and the amds gene in the codon optimized 
udh integration. Two in vitro gRNAs were designed to excise a DNA fragment (around 
541 bp) of the ORF 39114 targeting the exon 2 and the exon 3. Three transformations 
with different conditions were performed: 1) the ΔgaaA udh strain with pFC-332 (as a 
control), 2) the ΔgaaA udh strain with pFC-332 and two gRNAs and 3) the ΔgaaA udh 
strain with pFC-332, gRNA cleaving from the exon 3 and the deletion cassette as the 
donor DNA. The transformations were performed with around 10 µg of the gRNAs, 10 µg 
of the donor DNA and 1 µg of the pFC-332 plasmid. The resulting ΔgaaA udh Δ39114 
transformants were screened by colony PCR using primers pairs oPEEL-001 and 
oPEEL-029, oPEEL-059 and oPEEL-060 and oPEEL-088 and oPEEL-089 (Appendix 1 
Table 2). 
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6.5 Cultivation for galactaric acid production 
6.5.1 Cultivation with galacturonic acid 
The strains ΔgaaA udh Δ39114 and ΔgaaA udh were grown on SCGalA-URA (SC-URA 
containing 2 % galacturonic acid) plate and also submerged cultivated with galacturonic 
acid at different scales: 4 ml and 50 ml. The wild-type strain ATCC 1015 was also 
submerged cultivated for comparison. 
In the 4 ml-scale submerged cultivations, the strains ΔgaaA udh Δ39114, ΔgaaA udh and 
the wild-type strain were cultivated in two different mineral media, MM-GalA and 
MM-XGalA containing 20 g/l galactaric acid at initial pH 5 (Table 3). Cultivations were 
performed as in the cultivation of deletion mutants with galactaric acid (see 6.3.1) with 
few exceptions. In precultivation, the volume of the used spore suspension was 200 ‒
300 µl and the filtered mycelia were resuspended to MM-GalA medium. As earlier, there 
were two replicates, initial biomass concentration was 5 g wet cells mass/l and the 
cultures were incubated at 28 °C, 800 rpm for 5 days.  
The 50 ml-scale submerged cultivations were performed in 250 ml Erlenmeyer flasks. 
The strains ΔgaaA udh Δ39114, ΔgaaA udh and the wild-type strain were cultivated in 
MM-GalA and YP-GalA with intitial pH 5 or 3 with three replicates. The media were 
inoculated with around 0.5 g mycelia resuspended to the same cultivation medium, so 
that the initial mycelia concentration was 10 g wet cell mass/l. Cultures were incubated 
at 28 °C, 200 rpm for 5 days. 
The formation of galactaric acid and the consumption of galacturonic acid during the 
cultivations were followed by HPLC. The samples were taken at 24 h, 48 h, 72 h, 96 h 
and 120 h and prepared by filtering with 96 well MultiScreen HTS DV Filter Plate.  
6.5.2 Cultivation with citrus processing waste 
CPW prepared according to Kuivanen et al. (2014) was used as a substrate for SSF and 
SmF. The dry mass (DM) of the prepared CPW was determined by weighing the CPW 
before and after drying in an oven at 100 °C overnight. The fermentations were 
performed in 250 ml Erlenmeyer flasks with three replicates.  
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In the SSF, 6 ml of sterile water or 13 g/l (NH4)2SO4 containing an inoculum of 2×10
7 
ΔgaaA udh Δ39114 spores were mixed with 2 g of CPW. The cultures were incubated at 
28 °C for 137 h. After 3 days of cultivation, 2 ml of sterile water or (NH4)2SO4 was added 
to the cultures. The fermentation products were extracted by adding 30 ml of sterile 
water to the cultures followed by an incubation at 28 °C, 200 rpm for 1 h. The 
suspension was filtered with Glass Microfibre Filter (55mm diameter, Whatman, GE 
Healthcare Life Science, USA) with vacuum and the supernatant was analyzed with HPLC.  
In the SmF, 2 g of CPW was incubated with 50 ml A. nidulans defined minimal medium 
(NaNO3 6 g/l, KCl 0.52 g/l, MgCl2 0.52 g/l and KH2PO4 1.52 g/l, Barratt et al., 1965) 
inoculated with 10 g wet cell mass/l of the wild-type, the ΔgaaA udh and the 
ΔgaaA udh Δ39114 mycelia. The fermentations were done at 28 °C, 200 rpm for 5 days. 
Samples for HPLC was taken every 24 h and treated as in previous cultivations before 
analyzing with HPLC. 
6.6 Transformation procedures 
6.6.1 Transformation of S.cerevisiae – Gietz protocol 
Yeast transformation was done with S. cerevisiae following Gietz protocol with small 
modifications (Gietz Lab Transformation Kit Manual, Molecular Research Reagents Inc.). 
S. cerevisiae was inoculated from yeast glycerol stock with sterile loop to 50 ml YPD 
medium in 250ml Erlenmeyer flask. The yeast was precultivated at 30 °C, 250 rpm 
overnight. 3 ml of the preculture was inoculated to 50 ml YPD medium and incubated at 
30 °C, 250 rpm for around 3 h so that OD600 was around 1. 
Next, the cells were collected (4 °C, 5000 rpm, 5 min), and resuspended to 20 ml sterile 
water by vortexing followed by centrifugation (4 °C, 5000 rpm, 5 min). The cells were 
resuspended again in 1 ml sterile water and centrifuged (4 °C, 10 000 rpm, 30 s). The 
supernatant was removed by pipetting. Then the cells were resuspended in 350 µl 
sterile water by pipetting up and down. 50 µl of the cell suspension was transferred into 
a 1.5 ml Eppendorf tube, centrifuged (10 000 rpm, 15 s) and the supernatant was 
removed. 
Transformation mix containing 50 % PEG 4000 (240 µl), LiAc 1 M pH 7.5 (36 µl), ss-DNA 
(25 µl) and 100 ng plasmid DNA plus sterile water (50 µl) was added to the yeast cell 
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pellet. Then a heat shock was performed at 42 °C for 40 min in a heat block. After this, 
cells were centrifuged (5000 rpm, 1min) and resuspended in 1 ml sterile water. 100 µl of 
the cell suspension was plated to SCD-URA plate. The remaining 900 µl cell suspension 
was centrifuged (5000 rpm, 1min), the supernatant poured off and resuspended in the 
remaining supernatant around (100 µl). This cell suspension was also plated. Plates were 
incubated at 30 °C for 3-4 days. 
6.6.2 Transformation of E. coli –Electroporation 
3 µl of plasmid from Miniprep was added to 40 µl of electrocompetent cells. The mixture 
was transferred to electroporation cuvette and electroporation was performed at 
1.5 kV. Then 1 ml SOC solution was added. 100 µl of the cell suspension was plated on 
LB plate with 100 µg/ml ampicillin. The remaining 900 µl cell suspension was centrifuged 
(5000 rpm, 1 min) and SOC solution was poured off. The cell pellet was resuspended in 
the remaining SOC solution (around 100 µl) and plated. The plates were incubated at 37 
°C overnight. 
6.6.3 Transformation of A. niger – Protoplast method 
Protoplast method was used in the transformation of A. niger (Yelton et al., 1984). First, 
protoplasts were prepared for the transformation. Sufficient amount (300-500 µl) of 
spores were inoculated to 125 YP-G medium in 250 Erlenmeyer flask and grown at 28 °C, 
200 rpm for overnight. Then the germinated spores were filtered through a sterile Glass 
Microfibre Filter (55mm diameter, Whatman, GE Healthcare Life Science, USA) with 
vacuum and washed with 37 °C sterile water and cold KMC buffer (1 M KCl, 
25 mM CaCl2, 10 mM Tris-HCl, pH 5.8). Next, the mycelia were resuspended in 20 ml 
KMC buffer containing 200 mg caylase C4, incubated at 30 °C, 80 rpm for 3 h, and cooled 
on ice. The protoplasts were filtered through two layers of Miracloth (Calbiochem, 
Germany) prewet with cold KMC buffer. Filtration was done first without vacuum and 
towards the end with a soft vacuum. The protoplast solution was centrifuged (2 °C, 
1500 x g, 4 min). The supernatant was poured off and the protoplasts washed with 20 ml 
cold KMC buffer by resuspending the pellet. Centrifugation was repeated and washed 
with 20 ml cold transformation buffer by resuspending the pellet. The used 
transformation buffer was STC solution (1.33 M sorbitol,10 mM Tris-HCl, 50 mM CaCl2, 
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pH 8.0). The suspension was then centrifuged (2 °C, 1500 x g, 4 min), the supernatant 
removed and the pellet resuspended in STC solution 200 µl as the total volume.  
Around 10 µg of each DNA altogether in 100 µl STC solution was used in the 
transformation. First 100 µl of the protoplasts were added to the DNA and then 100 µl 
of the transformation solution (25% PEG 6000, 50 mM CaCl
2
, 10 mM Tris-HCl, pH 7.5) 
was added. The mixture was incubated on ice for 20 min. Then 2 ml transformation 
solution was added to the mixture and incubated at room temperature for 5 min. Next, 
4 ml STC solution was added to stop the reaction. 7 ml melt top agar (50 °C) was added 
to the mixture and mixed by inverting the tube and poured to the selection plate 
(SCD-URA transformation plate or hygromycin (400 µg/ml) transformation plate) 
immediately. Plates were incubated at 28 °C for 3-4 days. The top agar consists of the 
same components as the transformation plate.  
7 Results  
7.1 Deletion of the genes potentially involved in the galactaric acid 
catabolism 
In order to unravel the galactaric acid catabolic pathway based on transcriptomics data 
(not shown), eight genes, which were upregulated on galactaric acid and had a predicted 
function, were chosen for targeted deletion. Protein ID of these genes in Joint Genome 
Institute (JGI) are 39114, 1090836, 1117792, 1141260, 1121140, 1162477, 1146483 and 
1170646 (Table 4).  
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Table 4 Proteins which are potentially involved in the galactaric acid catabolism in 
A. niger, and their predicted functions. Protein ID refers to the number of Joint Genome 
Institute. 
Protein ID Predicted function 
39114 IPR000873: AMP-dependent synthetase and ligase 
1090836 IPR001395: Aldo/keto reductase 
1117792 IPR013149: Alcohol dehydrogenase, zinc-binding 
1141260 IPR002198: Short-chain dehydrogenase/reductase SDR 
1121140 IPR006076: FAD dependent oxidoreductase 
1162477 IPR000623: Shikimate kinase, Gluconokinase 
1146483 IPR013342: Mandelate racemase/muconate lactonizing enzyme, C-terminal 
1170646 IPR006139: D-isomer specific 2-hydroxyacid dehydrogenase, catalytic region 
 
The plasmids containing a deletion cassette were constructed to delete the eight 
potential genes involved in the galactaric acid catabolism from the ΔpyrG strain. 
A model of a plasmid containing a deletion cassette is shown in Figure 10. Each deletion 
cassette consists of specific flanking regions for the target gene and a pyrG gene as a 
selection marker for A. niger. 
 
 
Figure 10 A model of a plasmid containing deletion cassette, which consists of the 
cassette and backbone plasmid p2974. The cassette consists of two 1.5 kb flanking 
regions amplified from Aspergillus niger genome and a pyrG gene as a selection marker 
for A. niger. The flanking regions are specific for the gene of interest. The size of the 
cassette is around 5 kb and designed to be released with NotI. The backbone p2974 
(5.6 kb) have a bacteria and a yeast origin of replicon, ori and 2µ respectively, and genes 
amp (ampicillin resistance gene) and ura3 are selection marker for Escherichia coli and 
Saccharomyces cerevisiae respectively. 
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The deletion of the eight potential genes related to the galactaric acid pathway was 
attempted from the ΔpyrGΔkusA and ΔpyrG strains by homologous recombination. 
Transformants obtained from using the ΔpyrGΔkusA strain are more likely to be correct 
compare to the transformant obtained from the ΔpyrG strain. This is due to the deletion 
of kusA gene involved in NHEJ which will result in the decrease of random integration of 
the deletion cassette. However, no transformants were obtained by transforming the 
ΔpyrGΔkusA strain with the deletion cassettes. Therefore, only the ΔpyrG strain was 
manipulated. 
The deletions were first performed by homologous recombination. The primary 
transformants were screened by colony PCR and purified by single spore isolation. Then 
the strains were cultivated on galactaric acid. Because clones of the Δ39114 strain 
behaved differently when cultivated on galactaric acid, there was a worry about mixed 
population (mutants with correct deletion cassette integration and with random 
integration) also in other deletion mutants. Therefore, to confirm the correct integration 
of the deletion cassette and pureness of the culture, the 5’ and 3’ flanking regions of the 
cassette (Figure 11AB) and part of the ORF of the gene of interest (Figure 11C) were 
amplified. If both flanking regions and the ORF fragment were amplified the culture was 
assumed to not to be pure. If only the ORF fragment was amplified, the gene was not 
deleted. If only the cassette fragments were amplified, the culture was pure. The 
Δ39114 strain was only tested by amplifying the 5’ flanking region and the ORF, but the 
3’ flanking region was not tested. However, the Δ39114 strain was confirmed to be pure, 
because a clear phenotype could be detected when it was cultivated with galactaric 
acid. The pureness of the strain was later also confirmed by colony PCR.  
 
 
Figure 11 Fragments amplified in colony PCR for screening and purifying the deletion 
strains. Arrows represent the primers used in PCR. Size of the fragments are A) around 
1.5 kb, B) around 1.7 kb, C) 700-770 bp and D) 2.3-2.8 kb depending on the gene. 
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Generally, it was difficult to obtain pure strains when the deletion was performed by 
homologous recombination. All in all, identifying correct colonies and going through 
singles spores to purify the stains was done 3-7 times depending on the deletion. In 
most cases, 5’ and 3’ flanking region and ORF fragments were amplified (Figure 12 no2), 
indicating that in the mutant the gene was not deleted, but the cassette was still 
integrated to the correct place. In some cases, only 5’ flanking region and ORF was 
amplified (Figure 12 no1). In these cases, maybe the gene was only partially deleted. 
Some deletion mutants were also lost during screening and going through single spores. 
Only Δ39114 was purified with single spore isolation when the deletion was performed 
by homologous recombination. 
 
 
Figure 12 A gel picture of colony PCR when deleting genes by homologous 
recombination. Fragments size in the ladder are i = 2 kb, ii = 1.5 kb, iii = 1 kb and iv = 
750 bp. The amplified fragments in colony PCR were A = ORF (700-770 bp), B = 5’ 
flanking region (1.5 kb) and C = 3’ flanking region (1.7 kb). 
 
After the several attempts to delete the genes by homologous recombination and to 
purify the mutant strains, deletion with the CRISPR/Cas9 method using deletion 
cassettes as a donor DNA was performed. 8 primary transformants per deletion were 
screened by colony PCR (and plated to SCD-URA), but again ORF and both flanking 
regions were amplified. There were three different cases: only ORF, ORF+5’ flanking 
region and ORF+5’+3’ flanking regions (Figure 13 no1, no3, no2). Thus, colony PCR was 
performed with few colonies in which all three fragments were amplified, using primers 
binding outside of the 5’ flanking region and inside the ORF (Figure 11D). If nothing 
could be amplified, the gene should not be in its original place and, thus, the gene 
should have been deleted. In some colonies this fragment was amplified and in some 
 41 
 
not. After the primary transformants had gone through single spore isolation once, most 
of the clones did not have the ORF anymore and only the 5’ and 3’ flanking region of the 
deletion cassette were amplified (Figure 13 no4). After going through the single spore 
isolation for the second time, the ORF fragment was not amplified and 3’ flanking region 
was also not amplified in some clones. Nevertheless, in at least half of the screened 
clones only the flanking regions were amplified indicating that the deletion was correct. 
In total, the transformants were replated six times, alternating between SCD-URA and 
PD plates in order to screen and purify the strain by single spore isolation. 
 
 
Figure 13 A gel picture of colony PCR when deleting genes using the CRISPR/Cas9 
method. Fragments size in the ladder are i = 2 kb, ii = 1.5 kb, iii = 1 kb and iv = 750 bp. 
The amplified fragments in colony PCR were A = the ORF (700-770 bp), B = 5’ flanking 
region (1.5 kb), C = 3’ flanking region (1.7 kb) and D = 5’ flanking region and part of the 
ORF (2.3-2.8 kb depending on the gene). 
 
The use of CRISPR/Cas9 for gene deletion increased the deletion efficiency significantly. 
Comparison of deleting genes 1090836, 1117792, 1141260 and 1121140 by homologous 
recombination with deletion cassette and by the CRISPR/Cas9 method using two gRNAs 
and deletion cassette are shown in Table 5. With the CRISPR/Cas9 method, the 
efficiency was increased 8-fold when deleting the 1090836 gene and 2-fold when 
deleting the 1117792 gene. The homologous recombination efficiency was very low 
when deleting the genes 1141260 and 1121140. None of the 30 screened Δ1141260 
primary transformants had the gene deleted. In the case of the Δ1121140 primary 
transformants, only one primary transformant of the 60 screened transformants was 
correct. In fact, performing the deletion of the gene 1121140 again resulted in 0 correct 
transformants out of the 60 screened transformants. On the other hand, when the 
deletion was done with the CRISPR/Cas9 method, all 8 screened Δ1141260 
transformants were correct and 3 out of 8 screened Δ1121140 transformants were 
correct. 
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Table 5 Comparison of deleting four different genes with homologous recombination 
and the CRISPR/Cas9 mthod. Amplifying flanking regions of the deletion cassette by 
colony PCR was used to verify the correct transformants. Efficiency is percentage of 
correct transformants of total screened colonies.  
 
Homologous recombination CRISPR/Cas9 
Deletion Total Correct Efficiency (%) Total Correct Efficiency (%) 
1090836 30 1 3.3 40 11 27.5 
1117792 30 13 43.3 8 8 100 
1141260 30 0 0.0 8 8 100 
1121140 60 1 1.7 8 3 37.5 
7.2 New A. niger phenotype of lacking galactaric acid catabolism 
In order to screen new phenotypes, after the successful deletion of the genes and strain 
purification, two clones of each mutant stain, Δ39114, Δ1090836, Δ1117792, Δ1141260, 
Δ1121140, Δ1162477, Δ1146483 and Δ1170646, were cultivated with two replicates for 
5 days in three different media, MM-McA, MM-XMcA and YP-McA, containing 10 g/l of 
galactaric acid. The consumption of galactaric acid was analysed by HPLC. Mutants 
which did not consume galactaric acid were concluded to have a phenotype that was 
not described previously.  
The consumption of galactaric acid by the wild-type and the mutant strains was poor in 
MM-McA medium (Figure 14). Deletion of the genes 39114, 1090836, and 1121140 
resulted in strains, which did not consume galactaric acid when cultivated in MM-XMcA 
medium (Figure 15). In YP-McA medium, the consumption between the wild-type strain 
and the Δ39114 strain was clearly different (Figure 16). However, the Δ1090836 and 
Δ1121140 strains consumed galactaric acid in YP-McA, but the consumption was less 
compared to the wild-type strain. The wild-type strain consumed almost all galactaric 
acid in MM-XMcA and YP-McA media. Other deletion mutants, Δ1117792, Δ1141260, 
Δ1162477, Δ1146483 and Δ1170646 consumed galactaric acid and behaved more or less 
similar to the wild-type strain in all culture media. The increase in the galactaric acid 
concentration in the cultures was due to the evaporation of the medium during 
cultivation. The Δ39114 strain was also cultivated with glucaric acid and it did not 
consume the acid, whereas the wild-type strain consumed all (Figure 17). The Δ1162477 
was also grown on gluconic acid plates. It was assumed that the mutant might not grow, 
because the gene has homology to a gluconokinase and this activity was assumed to be 
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essential for gluconic acid catabolism. However, the growth of the Δ1162477 strain 
looked the same as the wild-type strain. 
 
Figure 14 Galactaric acid consumption of the wild-type strain ATCC 1015 and the 
Δ39114, Δ1090836, Δ1117792, Δ1141260, Δ1121140, Δ1162477, Δ1146483 and 
Δ1170646 strains during 5-day cultivation. The stains were cultivated in minimal 
medium with 10 g/l galactaric acid (MM-McA). Average of two clones and their two 
replicates are presented in the figure. Error bars represent ±standard deviation. The 
wild-type strain also has error bar of the time, because half of the samples were taken at 
significantly different time. 
 
Figure 15 Galactaric acid consumption of the wild-type strain ATCC 1015 and the 
Δ39114, Δ1090836, Δ1117792, Δ1141260, Δ1121140, Δ1162477, Δ1146483 and 
Δ1170646 strains during 5-day cultivation. The stains were cultivated in minimal 
medium with 0.5 % xylose and 10 g/l galactaric acid (MM-XMcA). Average of two clones 
and their two replicates are presented in the figure. Error bars represent ±standard 
deviation. The wild-type strain also has error bar of the time, because half of the 
samples were taken at significantly different time. 
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Figure 16 Galactaric acid consumption of wild-type strain ATCC 1015 and the Δ39114, 
Δ1090836, Δ1117792, Δ1141260, Δ1121140, Δ1162477, Δ1146483 and Δ1170646 strains 
during 5-day cultivation. The stains were cultivated in YP medium with 10 g/l galactaric 
acid (YP-McA). Average of two clones and their two replicates are presented in the 
figure. Error bars represent ±standard deviation. The wild-type strain also has error bar 
of the time, because half of the samples were taken at significantly different time. 
 
Figure 17 Glucaric acid consumption of the wild-type strain ATCC 1015 (◆) and the 
Δ39114 strain (■) during 5-day cultivation in YP medium with 10 g/l glucaric acid 
(YP-GlcA). Average of two replicates of wild-type and average of two clones and their 
two replicates of the Δ39114 strain are presented in the figure. Error bars represent 
±standard deviation. If the error bars are not visible, they are smaller than the symbols. 
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The colour change of the cultures was observed during the galactaric cultivation (Table 
6). The colour of the wild-type strain cultures were yellow in all media.  After 5 days, 
media of MM-McA cultures of the strains Δ1090836, Δ1141260, Δ1121140, Δ1146483 
and Δ1170646 and one clone of the Δ1117792 strain, had turned reddish, whereas the 
strains Δ39114 and Δ1162477 and another clone of Δ1117792 were yellow. In the case 
of MM-XMcA cultures, the Δ1090836 culture turned to orange, the Δ1121140 culture to 
orangish yellow and the rest to yellow. Media of YP-McA cultures remained yellow 
except Δ39114, Δ1090836 and Δ1121140 turned to dark orange or orange. The reason 
for the colour change is unknown. Probably the deletion had caused the formation and 
maybe also accumulation of some colour producing compounds. 
 
Table 6 The colour of galactaric acid cultures of different mutant strains after 5-day 
cultivation. 
Strain/Media MM-McA MM-XMcA YP-McA 
Wild-type Yellow Yellow Yellow 
Δ39114 Yellow Yellow Orange 
Δ1090836 Reddish Orange Dark orange 
Δ1117792 Reddish/Yellow Yellow Yellow 
Δ1141260 Reddish Yellow Yellow 
Δ1121140 Reddish Orangish yellow Orange 
Δ1162477 Yellow Yellow Yellow 
Δ1146483 Reddish Yellow Yellow 
Δ1170646 Reddish Yellow Yellow 
 
In order to express genes 39114, 1090836 and 1121140, which deletion resulted in the 
strains not able to utilize galactaric acid, in S. cerevisiae and measure the activity of the 
enzymes coded by these genes, the ORF of the genes 39114, 1090836 and 1121140 
were amplified from the cDNA and and ligated with the linearized yeast expression 
vector p2159. Then the whole ORF was sequenced to see whether intron prediction of 
JGI was correct. Intron prediction of JGI for the genes 39114 and 1090836 differed from 
the sequencing results. The gene 1121140 does not have introns as predicted in JGI. The 
sequence of the genes with introns are shown in Appendix 2. The ORF of the genes 
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39114, 1090836 and 1121140 was expressed in S. cerevisiae CEN.PK2-1D. Enzyme 
activity of the enzyme 39114 was tested. The activity of the 39114 enzyme was not 
detected when galactaric or glucaric acid were used as the substrate with cofactors: 
NADP, NADPH, NAD and NADH.  
7.3 Construction and cultivation of galactaric acid producing strains 
7.3.1 Construction of the Δ39114ΔgaaA/C::udh and Δ39114ΔgaaA/C udh 
strains 
In order to construct an A. niger strain which can produce galactaric acid, D-galacturonic 
acid and galactaric acid catabolic pathways must be blocked and D-galacturonate 
dehydrogenase for galactaric acid production must be expressed (Figure 18). Two 
different approaches for the deletion of the genes gaaA and gaaC (gaaA/C) coding for 
D-galacturonate reductase and 2-keto-3-deoxy-L-galactonate aldolase respectively in the 
D-galacturonic acid catabolic pathway from the strain Δ39114 were developed. First, the 
deletion was attempted by integrating the udh gene coding for D-galacturonate 
dehydrogenase derived from P. syringae to the gaaA/C locus by homologous 
recombination using an udh integration cassette (resulst in Δ39114ΔgaaA/C::udh strain). 
Secondly, the CRISPR/Cas9 method was utilized to delete gaaA/C (results in 
Δ39114ΔgaaA/C strain) and then randomly integrate the udh gene to the genome 
simultaneously or later (results in Δ39114ΔgaaA/C udh strain). In the genome, the genes 
gaaA and gaaC are located next to each other separated only by a bidirectional 
promoter. Therefore, simultaneous deletion of the genes would be possible.  
In order to delete the gaaA/C from the Δ39114 strain and express the udh, construction 
of a plasmids containing the udh integration cassette was attempted. The fragments of 
the plasmid (two flanking regions, udh and backbone plasmid) were amplified by PCR 
and attempted to assemble using homologous recombination in S. cerevisiae, TOPO 
Cloning or Gibson Assembly. In TOPO Cloning, the amplification of integration cassette 
as one fragment occurred because of the 40 bp overhangs of the templates capable of 
annealing to each other The integration cassette could not be obtained with any of the 
tried methods. When assembling integration cassette using yeast homologous 
recombination and Gibson Assembly, only the 5’ flanking region was amplified by colony 
PCR. When using TOPO Cloning both flanking region fragments could not be amplified. 
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Figure 18 Catabolism of D-galacturonic acid in A. niger can be blocked by deleting 
D-galacturonate and 2-keto-3-deoxy-L-galactonate aldolase of the catabolic pathway. 
Expressing a D-galacturonate dehydrogenase would enable the production of galactaric 
acid in A. niger, if the galactaric acid catabolic pathway is also blocked. 
 
Because the udh integration cassette could not be obtained with yeast homologous 
recombination, TOPO Cloning nor Gibson Assembly, the CRISPR/Cas9 method was 
applied for simultaneous deletion of the gaaA/C gene and the integration of the udh 
gene in the Δ39114 strain and inactivation of the gaaA/C gene in the Δ39114 strain. 
When using the CRISPR/Cas9 method in gene deletion, 1 µg of plasmid pFC-332 was 
enough for transformation. The transformation was also done with 10 µg, but it led to 
the overgrowth of the transformants. The plasmid pFC-332 is an autonomously 
replicating vector harboring AMA1 (autonomous maintenance in Aspergillus) sequence 
and a hph (hygromycing resistance) gene as a selection marker. Under the selective 
conditions, the plasmid pFC-332 is maintained in the cell, but readily lost without 
selection. Least primary transformants were obtained in the Δ39114ΔgaaA/C::udh 
strain, more with the Δ39114ΔgaaA/C strain and most with the control strain. The 
Δ39114ΔgaaA/C transformants were screened by colony PCR. The PCR fragment size of 
colonies, in which the gaaA/C gene is deleted, should be around 200 bp assuming there 
were no indels. Integration of the udh gene to the gaaA/C locus would results in a 2691 
bp fragment and if the gaaA/C gene was not deleted, the fragment size would be 3406 
bp. In 9 out of 26 screened colonies, the gaaA/C (3.4 kb) was not amplified, but the 200 
bp fragment could also not be observed. These results does not confirm the deletion of 
the gaaA/C gene. However, the 200 bp fragment is quite small to be seen on the gel. 
 48 
 
Therefore, these colonies were also screened by cultivating on SCGalA-URA plates. The 
deletion of the gaaA/C gene should result in the strain not being able to grown on 
galacturonic acid. However, the clones were still able to grow on galacturonic acid 
suggesting that the gaaA/C gene was not deleted. A possible explanation to the colony 
PCR and growth results could be that the gaaA/C gene was deleted, but this deleted 
cluster integrated back to the genome randomly to a different place. The 
Δ39114ΔgaaA/C::udh transformants were also screened by colony PCR. Totally, 52 
colonies were screened but the udh gene was not amplified. The results showed again 
that the gaaA/C gene was still in the genome or that it was possibly deleted from its 
original locus. As a conclusion, with this approach the gaaA/C gene was not deleted nor 
the udh gene integrated.  
7.3.2 Construction of the ΔgaaA udh Δ39114  strain 
Since the strains Δ39114ΔgaaA/C::udh and Δ39114ΔgaaA/C udh could not be 
constructed due to unsuccessful construction of the udh integration cassette and 
deletion of the gaaA/C gene, a new approach was applied. In this approach, the 39114 
gene was deleted from the ΔgaaA udh stain using the CRISPR/Cas9 method. The 
deletion was performed in two different ways, using two gRNAs and one gRNA with the 
deletion cassette as a donor DNA. Least primary transformants were obtained in the 
transformation with the ΔgaaA udh strain with two gRNAs, then the control 
transformation and the ΔgaaA udh strain with one gRNA and deletion cassette. 24 
primary transformants of the construction of the ΔgaaA udh Δ39114 strain without the 
cassette were screened, but none of these transformants had shorterned ORF, as would 
be expected if the gene was inactivated with two DSBs. 2 out of the 24 screened primary 
transformants of the construction of the ΔgaaA udh Δ39114 strain with deletion 
cassette were correct. In these transformants, the ORF and the 5’ and the 3’ flanking 
regions were amplified in colony PCR. During the purification of the one correct 
transformant, only the 5’ and 3’ flanking regions were amplified and the ORF was not, 
indicating the successful deletion of the 39114 gene and that the culture is pure. In the 
purification of another correct transformants after going through single spores once, 
only the ORF was amplified or in 2 out of the8 screened colonies the ORF and the 3’ 
flanking region was amplified. 
 49 
 
7.3.3 Cultivation of the ΔgaaA udh Δ39114 strain 
Two clones of the strain ΔgaaA udh Δ39114 and the parent strain ΔgaaA udh were 
grown on SCGalA-URA plate (Figure 19). After incubating the galacturonic acid plate at 
28 °C for 3 days, the parent strain ΔgaaA udh had formed a white colony and sporulated 
and the ΔgaaA udh Δ39114 strain had formed a yellow colony without any spores. The 
ΔgaaA udh Δ39114 strain grew slower than ΔgaaA udh strain. The size of the 
ΔgaaA udh Δ39114 colony is also smaller and much thinner than the ΔgaaA udh colony. 
 
 
Figure 19 Cultivation of the parent strain ΔgaaA udh and the mutant strain 
ΔgaaA udh Δ39114 on SCGalA-URA agar plate, 28 °C, 3 days. The ΔgaaA udh strain had 
formed a white colony which had started to sporulate, whereas the ΔgaaA udh Δ39114 
strain had formed a smaller and thinner yellow colony without spores. 
 
The strains ΔgaaA udh Δ39114 and ΔgaaA udh were also cultivated in submerged 
cultivations in different scales in different media. Initial concentration of galacturonic 
acid was 20 g/l in all cultivations. In 4 ml-scale cultivation, the strains ΔgaaA udh Δ39114 
and ΔgaaA udh were cultivated in MM-GalA medium (Figure 20) and MM-XGalA 
medium (Figure 21) with initial pH of 5. The ΔgaaA udh culture had turned to yellow in 
both medium after 5 days and the ΔgaaA udh Δ39114 culture had turned light yellow. In 
MM-GalA cultivations, the ΔgaaA udh strain consumed galacturonic acid, but did not 
produced galactaric acid. The ΔgaaA udh Δ39114 strain did not consume much 
galacturonic acid, but was able to produce 0.8 ± 0.03 g/l of galactaric acid. The increase 
of galacturonic acid is due to the evaporation of the medium during cultivation. The 
evaporation might have also affected galactaric acid concentration. In MM-XGalA 
cultivations, similar patterns of galactaric acid consumption as in the MM-GalA 
cultivations can be seen in both strains. However, both strains were able to produce 
galactaric acid. After 48 h the ΔgaaA udh strain produced 0.5 ± 0.02 g/l galactaric acid, 
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but it was all consumed after 120 h. Whereas the ΔgaaA udh Δ39114 strain produced 
1.1 ± 0.04 g/l of galactaric acid.  
 
 
Figure 20 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 4 ml MM-GalA medium 
(pH 5) by the strains ΔgaaA udh (■) and ΔgaaA udh Δ39114 (▲). Average of two 
replicates of the ΔgaaA udh and average of two clones and their two replicates of the 
ΔgaaA udh Δ39114 are presented in the figure. Error bars represent ±standard 
deviation. If the error bars are not visible, they are smaller than the symbols. 
 
Figure 21 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 4 ml MM-XGalA medium 
(pH 5) by the strains ΔgaaA udh (■) and ΔgaaA udh Δ39114 (▲). Average of two 
replicates of the ΔgaaA udh and average of two clones and their two replicates of the 
ΔgaaA udh Δ39114 are presented in the figure. Error bars represent ±standard 
deviation. If the error bars are not visible, they are smaller than the symbols. 
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In 50 ml-scale submerged cultivation, the strains ΔgaaA udh Δ39114, ΔgaaA udh and 
wild-type were cultivated in the MM-GalA and the YP-GalA media with initial pH 5 or 
pH 3 and in the MM-XGalA medium with initial pH 5 for 5 days. All MM-GalA cultures 
with initial pH 5 turned to light yellow after 24 h, and after 120 h the wild-type and the 
ΔgaaA udh cultures were brown whereas the ΔgaaA udh Δ39114 cultures were still 
yellow. With the initial pH of 3, all MM-GalA cultures were clear after 24 h, and after 
120 h the wild-type cultures was brownish orange, the ΔgaaA udh cultures had brown 
cells and yellow supernatant and the ΔgaaA udh Δ39114 cultures was light yellow. The 
MM-XGalA cultures of the wild-type and the ΔgaaA udh strains were brown and the 
ΔgaaA udh Δ39114 strain were yellow brown. The colour of the YP-GalA cultures of the 
wild-type, the ΔgaaA udh and the ΔgaaA udh Δ39114 strains after 120 h with initial pH 5 
were yellow brown, yellow brown and dark brown, and with initial pH 3 the cultures 
were dark brown, brown and brown yellow, respectively. In general, the size of the cell 
was the smallest in the ΔgaaA udh Δ39114 cultures, and the wild-type strain had 
produced most biomass.  
The consumption of galacturonic acid and the production of galactaric acid during the 
cultivations are shown in Figure 22 – Figure 26. In general, the wild-type strain 
consumed all galacturonic acid after 48 h and the ΔgaaA udh strain consumed all or 
almost all after 48, 72 or 120 h. The ΔgaaA udh Δ39114 strain consumed very little 
galacturonic acid in the MM-GalA media, but a clear consumption could be seen in the 
YP-GalA media. The wild-type strain did not produce galactaric acid in any medium. The 
ΔgaaA udh strain did not produce galactaric acid in the MM-GalA with initial pH 5, 
however with initial pH 3 it produced 0.3 ± 0.009 g/l galactaric acid after 48 h. 
Nevertheless, all produced galactaric acid was consumed after 120 h. The 
ΔgaaA udh Δ39114 strain was able to produce 1.5 ± 0.03 g/l galactaric acid after 120 h in 
the MM-GalA medium with initial pH 5 and 0.9 ± 0.02 g/l in the MM-GalA medium with 
initial pH 3. In the MM-XGalA medium with initial pH 5, the ΔgaaA udh strain produced 
0.4 ± 0.009 g/l galactaric acid after 24 h, but they were all consumed after 48 h. The 
ΔgaaA udh Δ39114 strain produced 1.5 ± 0.5 g/l galactaric acid after 120 h which is 
almost same as in the MM-GalA medium. The production rate was, however, higher in 
the MM-XGalA medium compared to in the MM-GalA medium.  In the YP-GalA medium 
compared to mineral media, galactaric acid production was improved. In the YP-GalA 
medium with initial pH of 5, the ΔgaaA udh strain produced 1.2 ± 0.02 g/l and the 
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ΔgaaA udh Δ39114 strain 4.3 ± 0.2 g/l galactaric acid after 120 h. With initial pH of 3 the 
production was 1.0 ± 0.02 g/l and 3.4 ± 0.1 g/l, respectively. 
 
 
Figure 22 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 50 ml MM-GalA medium, 
pH 5 by strains wild-type (◆), ΔgaaA udh (■)and ΔgaaA udh Δ39114 (▲). Average of 
three replicates is presented in the figure. Error bars represent ±standard deviation. If 
the error bars are not visible, they are smaller than the symbols.  
 
Figure 23 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 50 ml MM-GalA medium, 
pH 3 by strains wild-type (◆), ΔgaaA udh (■)and ΔgaaA udh Δ39114 (▲). Average of 
three replicates is presented in the figure. Error bars represent ±standard deviation. If 
the error bars are not visible, they are smaller than the symbols. 
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Figure 24 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 50 ml MM-XGalA medium, 
pH 5 by strains wild-type (◆), ΔgaaA udh (■)and ΔgaaA udh Δ39114 (▲). Average of 
three replicates is presented in the figure. Error bars represent ±standard deviation. If 
the error bars are not visible, they are smaller than the symbols. 
 
Figure 25 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 50 ml YP-GalA medium, pH 
5 by strains wild-type (◆), ΔgaaA udh (■)and ΔgaaA udh Δ39114 (▲). Average of three 
replicates is presented in the figure. Error bars represent ±standard deviation. If the 
error bars are not visible, they are smaller than the symbols. 
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Figure 26 Consumption of galacturonic acid (GalA, blue symbols) and formation of 
galactaric acid (McA, red symbols) during 5-day cultivation in 50 ml YP-GalA medium, pH 
3 by strains wild-type (◆), ΔgaaA udh (■)and ΔgaaA udh Δ39114 (▲). Average of three 
replicates is presented in the figure. Error bars represent ±standard deviation. If the 
error bars are not visible, they are smaller than the symbols. 
 
The ΔgaaA udh Δ39114 strain was also fermented in SSF and SmF using CPW as the 
substrate. The wild-type strain and the ΔgaaA udh strain were also fermented in SmF 
using CPW as the substrate. After keeping 4.0438 g of dried CPW at 100 °C, it mass had 
reduced to 3.7858 g. Therefore, 1 g CPW represents 0.936 g on a DM due to residual 
water. In the SSF using CPW as a substrate, the ΔgaaA udh Δ39114 strain was able to 
produce 16.7 ± 0.9 mg galactaric acid from 2 g (1.87 g DM) CPW 
(8.9 ± 0.5 mg galactaric acid/g DM CPW) in 137 h. When nitrogen was also 
supplemented, the production increased to 28.9 ± 1.1 mg galactaric acid from 2 g CPW 
(15.4 ± 0.6 mg galactaric acid/g DM CPW). In the SmF, the peel waste was degraded 
after 24 h and no particles were visible. The wild-type strain and the ΔgaaA udh  strain 
did not produce galactaric acid, but the ΔgaaA udh Δ39114 strain had produced 
3.1 ± 0.1 g/l galactaric acid from 40 g/l (37.4 g/l DM) CPW (82.3 ± 3.9 mg galactaric 
acid/g DM CPW) after 120 h (Figure 27). Galacturonic acid was probably released to the 
liquid faster in the fermentation with the wild-type strain and the ΔgaaA udh strain than 
with the ΔgaaA udh Δ39114 strain. The wild-type strain and the ΔgaaA udh   strain also 
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consumed the galacturonic acid faster. In the fermentation with the ΔgaaA udh Δ39114 
strain after 120 h, 8.4 ± 0.06 g/l galacturonic acid was released.  
 
 
Figure 27 Submerged fermentation of the strains wild-type (◆), ΔgaaA udh (■) and 
ΔgaaA udh Δ39114 (▲) using citrus processing waste as the substrate. The figure shows 
the release of galacturonic acid (GalA,blue) and the production of galactaricacid 
(McA,red). The wild-type strain and the ΔgaaA udh did not produce galactaric acid. 
8 Discussion 
8.1 Strategies for gene deletion in A. niger 
The deletion of potential genes involved in galactaric acid pathway was attempted using 
two different strains, the ΔpyrG and the ΔpyrGΔkusA strains, and two methods, 
homologous recombination and CRISPR/Cas9. The kusA deletion should have facilitated 
the homologous recombination, however, no transformants were obtained by 
transforming the ΔpyrGΔkusA strain with the deletion cassettes. It has been reported 
that deleting the kusA gene might result in an unstable strain due to the weakened 
ability to repair DSBs. SSBs, on the other hand, can be repaired by KusA independent 
repair mechanisms. The ΔkusA strain is more sensitive towards UV and X-ray radiation 
than the wild-type strain. (Meyer et al., 2007) Therefore, it is possible that some 
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modification had occurred in the ΔpyrGΔkusA strain which had weakened the 
performance of homologous recombination. With the ΔpyrG strain transformants were 
obtained when using homologous recombination, however, it was difficult to obtain a 
pure strain even after several purification rounds. In some cases, the deletion cassette 
was apparently integrated to the correct place, but the ORF was still detected. An 
explanation could be that there is more than one copy of the gene or the stain has 
become a heterokaryon. If the genes of interest would be essential for the survival for 
the cell, this would explain the difficulty to delete it (Meyer et al., 2007). However, these 
genes are not believed to be essential.  
When deleting genes with theCRISPR/Cas9 method using a donor DNA, the donor DNA 
needs sufficiently long flanks. Deleting potential genes related to the galactaric acid 
pathway using the CRISPR/Cas9 method and a deletion cassette with a selection marker 
as a donor DNA increased the probability of obtaining the correct strain significantly. In 
the case of constructing the Δ39114ΔgaaA/C::udh strain using the CRISPR/Cas9, the 
gene gaaA/C was not successfully deleted from the Δ39114 strain when using the 
gpdA-udh integration cassette with 60 bp flanking regions as a donor DNA. On the other 
hand, when generating the ΔgaaA udh Δ39114 strain, the 39114 gene was deleted by 
CRISPR/Cas9 using the deletion cassette with 1.5 kb flaking regions as a donor DNA. It is 
probable that the 60 bp flanking regions were too short to trigger homologous 
recombination, because short flanking regions decrease the HR frequency. Flanking 
regions shorter than 200 bp have shown to reduce HR frequency significantly. 
Apparently, HR machinery is not able to mediate integration efficiently when the length 
of the flanking region is too short. Using flanking regions of 1-1.5 kb would give higher 
HR frequency. (Meyer et al., 2007) The 60 bp flanking regions were decided to use in the 
deletion, because it was thought that this low frequency problem might be overcome 
when using CRISPR/Cas9 technology due to the efficiency of CRISPR/Cas9, however, this 
was not the case. 
The deletion using the CRISPR/Cas9 method without a donor DNA harbouring selection 
marker gave poor results. Despite of efforts to delete the gene gaaA/C from the Δ39114 
strain with the CRISPR/Cas9 without donor DNA, the Δ39114ΔgaaA/C strain was not 
obtained. In addition, in the construction of the ΔgaaA udh Δ39114 strain, inactivation 
of the gene 39114 was also not successful. Pressure of selection brought by donor DNA 
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with selection marker would naturally ease the deletion. However, if the selection was 
still needed in gene deletion using the CRISPR/Cas9 method, the benefit of using the 
CRISPR/Cas9 would be lost although it increases the transformation frequency. The gene 
deletions in this study were conducted with two gRNAs. Using one gRNA should be 
sufficient to inactivate gene, however, this was not tested in this study. Furthermore, 
there is a possibility that in vitro gRNA does not work as well as in vivo gRNA. Thus, using 
in vivo gRNA could be a solution for deleting genes without selection. 
8.2 Galactaric acid pathway 
Deleting the genes 39114 or 1090836 resulted in a strain with a new phenotype of not 
utilizing galactaric acid. Moreover, deleting the 1121140 gene weakened the ability of 
A. niger to utilize galactaric acid. The Δ39114 strain also did not utilize glucaric acid. A 
hypothesis was that in the catabolic pathway, galactaric acid could be reduced to 
galacturonic acid and further to galactonic acid, and the rest would be the same as in 
the galacturonic catabolism. The enzyme 39114 is predicted to be AMP-dependent 
synthetase and ligase. It was thought that the enzyme 39114 could be the first enzyme 
in the pathway and reduce the galactaric acid. Therefore, the enzyme 39114 was 
expressed in S.  cerevisiae and its activity was tested using galactaric acid as the 
substrate. Enzyme activity was also tested with glucaric acid, since the Δ39114 strain 
also did not utilized the glucaric acid. However, the enzyme 39114 showed no activity on 
these substrates. Nevertheless, the enzyme 39114 must be related to the galactaric acid 
pathway, since deletion of this gene resulted in a phenotype of no galactaric acid 
catabolism. It is possible that the enzyme activity was not detected, because the enzyme 
assay conditions were not optimal for measuring the activity of the 39114 enzyme or 
that the yeast was not able to express the gene or translate it to an active protein. 
Another explanation is that the 39114 enzyme is not the first enzyme of the catabolic 
pathway. Enzymes 1090836 and 1121140 are also part of the galactaric acid pathway, 
based on cultivation results. The enzyme 1090836 is predicted to be aldo/keto 
reductase. The aldo-keto reductase family includes monomeric NADPH-dependent 
oxidoreductases. Therefore, another hypothesis is that the 1090836 enzyme could 
catalyse the oxidation of galactaric acid to 2-keto-galactarate with NAD+ or NADP+ as 
cofactors. The enzyme 1121140 is predicted to be FAD-dependent oxidoreductase. 
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Deletion of the 1121140 gene might have resulted in the accumulation of an 
intermediate, which could not be catabolized further. Enzymes 39114, 1090836 and 
1121140 need more investigations to characterize their possible role in the pathway. 
The activity of the enzymes 1090836 and 1141120 still need measured. The ability of the 
strains Δ1090836 and Δ1121140 to grown on other hexaric acid, such as, glucaric acid 
has also not been tested, thus, it is unclear whether these genes also block the glucaric 
acid utilization. 
8.3 Gluconokinase 
The gene 1162477 was confirmed not to be related to the galactaric acid catabolism. 
However, the enzyme 1162477 was annotated to be gluconokinase, thus, the enzyme 
could be involved in the gluconate catabolism. Therefore, the Δ1162477 strain was 
assumed not being able to utilize gluconic acid. However, the growth of Δ1162477 on 
2 % gluconic acid plate looked same as compared to the wild-type strain. The 
assumption might be wrong, because also some S. cerevisiae gluconokinase mutants are 
still able to grow slowly on gluconolactone (van Dijken et al., 2001). In the genome, 
there is a shorter gene with similar predicted function, which also might have some 
effect to the gluconic acid consumption. 
8.4 Engineering A. niger for galactaric acid produciton 
The production of galactaric acid from galacturonic acid by A. niger was successfully 
improved in this study. Previously, it has been reported that the A. niger ΔgaaA udh 
strain, in which the gaaA gene was deleted and the udh gene expressed, produced 
0.16 g galactaric acid/g galacturonic acid in 4 days. Its parent strain ΔgaaA was unable to 
grow on galacturonic acid, but expressing udh restored the ability to grow on 
galacturonic acid. This showed that the galactaric acid was catabolized by the ΔgaaA udh 
strain. (Mojzita et al,. 2010) Deletion of the gaaA gene does not block the galacturonic 
acid pathway completely, whereas deleting the gaaC gene does. Therefore, it was 
thought that the double deletion of the genes gaaA and gaaC would be an efficient and 
secure way to block the galacturonic acid pathway. However, the gaaA/C could not be 
deleted from the Δ39114 strain. Therefore, the gene 39114 was deleted from the 
ΔgaaA udh strain. The resulting strain, ΔgaaA udh Δ39114, was able to produce 4.3 ± 0.2 
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g/l galactaric acid from galacturonic acid with calculated yield of 1.5 ± 0.3 g galactaric 
acid/g galacturonic acid in 5 days as submerged shake flask fermentation, which is 
higher than its parent strain ΔgaaA udh which produced at best 1.2 ± 0.02 g/l galactaric 
acid with calculated yield of 0.067 ± 0.001 g galactaric acid/g galacturonic acid. The 
calculated yield obtained by the ΔgaaA udh Δ39114 strain is higher than the theoretical 
yield of 1.08 g galactaric acid/g galacturonic acid, which may be due to evaporation 
during the cultivation. Effect of the evaporation should have been taken into account in 
order to confirm the actual yield. Nevertheless, the actual yield is believed to be very 
close to the theoretical yield or even be the same.  
8.5 Comparison with other galactaric acid producing strains 
The ΔgaaA udh Δ39114 strain is superior to other galactaric acid producing strains. For 
example, the ΔgaaA udh Δ39114 strain produced same amount of galactaric acid in 
shorter time than T. reesei. With T. reesei QM6a Δgar 1 udh the obtained yield was 1.08 
g galactaric acid/g galacturonic acid in 211 h (Mojzita et al., 2010) whereas the 
ΔgaaA udh Δ39114 strain could do the same in 120 h. The ΔgaaA udh Δ39114 strain can 
also produce more galactaric acid than E. coli. With E. coli BL21(DE3) ΔuxaC ΔgarD udh 
the yield was 0.73 g galactaric acid/g galacturonic acid in 48 h (Zhang et al., 2016) 
whereas the ΔgaaA udh Δ39114 strain produced 1.4 ± 0.1 g galactaric acid/g 
galacturonic in 48 h. A. niger produces more hydrolytic enzymes than T. reesei, which is 
an advantage when pectin-rich residues are wanted to use as a substrate. Furthermore, 
using A. niger has a clear advantage compared to using E. coli, because E. coli does not 
naturally produce hydrolytic enzymes and the substrate would need a separate enzyme 
treatment.  
8.6 Physiology 
Additional carbon source is needed for growth to improve galacturonic acid conversion 
in the ΔgaaA udh Δ39114 strain. Lowering initial cultivation pH from 5 to 3 decreased 
the galactaric acid production. The same pH-dependent production was also observed 
by Mojzita et al. (2010) and Zhang et al. (2016). An explanation is that optimal pH and 
temperature for A. tumefaciens Udh are pH 8.0 and 35 °C (Zhang et al., 2016).  
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In this study, it was also shown that the strain ΔgaaA udh Δ39114 could produce 
16.7 ± 0.9 mg galactaric acid directly from 2 g (1.87 g DM) CPW in SSF, and when the 
nitrogen was also supplemented the production increased to 28.9 ± 1.1 mg galactaric 
acid corresponding to 8.9 ± 0.5 and 15.4 ± 0.6 mg galactaric acid/g DM CPW, 
respectively. Furthermore, the galactaric acid production was increased when the 
fermentation was performed with the SmF. In this case, the production was 
3.1 ± 0.1 g/l galactaric acid from 40 g/l (37.4 g/l DM) CPW corresponding to 
82.3 ± 3.9 mg galactaric acid/g DM CPW. L-galactonic and L-ascorbic acid have been 
produced from CPW with engineered A. niger (Kuivanen et al., 2014; Kuivanen et al., 
2015). The ΔgaaB and ΔgaaB-gaaA strains were able to produce 223 ± 2 and 221 ± 6 mg 
L-galactonic acid/g CPW in SSF from CPW, respectively. In SmF, these strains produced 
157 ± 3 and 159 ± 3 mg L-galactonic acid/g CPW. (Kuivanen et al., 2014) The ΔgaaB 
strain has also been further engineered to produce L-ascorbic acid from CPW. The 
obtained yield with the ΔgaaB-Eg-Mg (PgaaA/C) strain was 
4.25 mg L-ascorbic acid/g CPW. As a conclusion, engineered A. niger have great 
potentials in producing value-added products from pectin-rich residues. Since A. niger is 
naturally capable of degrading plants, no enzymatic pretreatment to the plant-based 
residue would be needed, which is the advantage of using A. niger.  
In the future, it would be interesting to investigate larger scale SSF or SmF by the 
ΔgaaA udh Δ39114 strain using citrus peel directly as a substrate. The fermentation 
conditions of the SSF would need optimization, for example, the humidity could be 
controlled. In this study, the SSF was done without controlling the humidity. In the SmF, 
the effect of inoculated amount of mycelia to the production could also be investigated. 
Moreover, starting the SmF by inoculating spores directly to the culture medium instead 
of inoculating pre-grown mycelia would be interesting. In addition, the effect to 
galactaric acid production by blocking galactaric acid by deleting the genes 1090836 and 
1121140 compared to the deletion of the gene 39114 could also be investigated. 
Deleting the genes 1090836 or 1121140 alone might not improve the production, but 
double deletion with 39114 might have a more effective impact. 
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9 Conclusions 
Three genes 39114, 1090836 and 1121140 were identified to be involved in the 
galactaric acid catabolic pathway in A. niger. Genes 1117792, 1141260, 1162477, 
1146483 and 1170646 do not take part in galactaric acid pathway.  
An A. niger strain with improved galactaric acid production was successfully constructed. 
Blocking galacturonic acid and galactaric acid catabolism by deleting genes gaaA and 
39114, repectively, from A. niger and expressing heterologous gene udh, resulted in a A. 
niger strain, ΔgaaA udh Δ39114, which could produce 4.3 ± 0.2 g/l galactaric acid from 
20 g/l galacturonic acid in rich medium with a high yield suggesting stoichiometric 
conversion. In addition when the strain was fermented with CPW, it produced 15.4 ± 0.6 
mg galactaric acid/g DM CPW from 2 g (1.87 g DM) CPW in SFF when nitrogen was 
supplemented and 82.3 ± 3.9 mg galactaric acid/g DM CPW from 40 g/l (37.4 g/l DM) 
CPW in SmF when using A. nidulans defined minimal medium. 
CRISPR/Cas9 technology improves gene deletion in A. niger and quicken the purification 
of mutant strains. According to the best of my knowledge, this is the first report of using 
in vitro gRNA successfully in A. niger for gene deletion using CRISPR/Cas9 genome 
editing tool. 
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Table 1 List of primers used to amplify 5’ flanking reagion and 3’ flanking region from Aspergillu niger ATCC1015 genome for deletion cassette 
constriction for the genes 39114, 1090836, 1117792, 1141260, 1121140, 1162477, 1146483 and 1170646 (JGI protein ID numbers) . 
Primer 
name Sequence Usage 
oPEEL-
002 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCGTGAAGACCTCGATTTGACC 
For the deletion cassette of ID1162477 
(gluconokinase), 5´flank for, flank for EcoRI/BamHI 
digested B2974 
oPEEL-
003 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGCAGAACTTATGTATGACGTC 
For the deletion cassette of ID1162477 
(gluconokinase), 5´flank rev, flank for XmaI digested 
pyrG (B4343) 
oPEEL-
004 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACTCCTGACACCTCTATTGAGC 
For the deletion cassette of ID1162477 
(gluconokinase), 3´flank for, flank for XmaI digested 
pyrG (B4343) 
oPEEL-
005 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCGCAGATAGACATGCCTGAAC  
For the deletion cassette of ID1162477 
(gluconokinase), 3´flank rev, flank for EcoRI/BamHI 
digested B2974 
oPEEL-
007 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCCACGCGTTTCCACATCTTCT 
For the deletion cassette of ID1146483 (dgdB), 5´flank 
for, flank for EcoRI/BamHI digested B2974 
oPEEL-
008 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGATTAGCAATGTGCTGCTTGC 
For the deletion cassette of ID1146483 (dgdB), 5´flank 
rev, flank for XmaI digested pyrG (B4343) 
oPEEL-
009 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACGTGATTGCGGAGGTGATCTG 
For the deletion cassette of ID1146483 (dgdB), 3´flank 
for, flank for XmaI digested pyrG (B4343) 
oPEEL-
010 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCGAAACTGATCGATCAGTCAC 
For the deletion cassette of ID1146483 (dgdB), 3´flank 
rev, flank for EcoRI/BamHI digested B2974 
oPEEL-
017 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCGACAGGGTTGAGCCAGTCTA 
5' flank aplification for An ID 1090836 del cassette, For, 
flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
018 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGTGCGACTAGTTGGGTGTCAC 
5' flank aplification for An ID 1090836 del cassette, 
Rev, flank for pyrG (pPEEL-002) 
oPEEL-
019 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACCAGGATTGTACAACTTAGTT 
3' flank aplification for An ID 1090836 del cassette, For, 
flank for pyrG (pPEEL-002) 
oPEEL-
020 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCGTACATCTCAGGGTAATATC 
3' flank aplification for An ID 1090836 del cassette, 
Rev, flank for EcoRI/BamHI dig pPEEL-001 
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oPEEL-
024 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCCTACGAGCCGTAGATTGCGT 
5' flank aplification for An ID 1117792 del cassette, For, 
flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
025 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGATGCATGGATGCATGGATAC 
5' flank aplification for An ID 1117792 del cassette, 
Rev, flank for pyrG (pPEEL-002) 
oPEEL-
026 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACCAGTCGTGTTAAAGCGATCC 
3' flank aplification for An ID 1117792 del cassette, For, 
flank for pyrG (pPEEL-002) 
oPEEL-
027 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCAAGGAGCGCGAGGGAATCAGC 
3' flank aplification for An ID 1117792 del cassette, 
Rev, flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
031 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCGAACCAGGCGCAGCGGATC 
5' flank aplification for An ID 1141260 del cassette, For, 
flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
032 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGCTTTCTTACGACGTTGATCC 
5' flank aplification for An ID 1141260 del cassette, 
Rev, flank for pyrG (pPEEL-002) 
oPEEL-
033 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACGTCCTGTAGTAGTAGGATAA 
3' flank aplification for An ID 1141260 del cassette, For, 
flank for pyrG (pPEEL-002) 
oPEEL-
034 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCGTTGCTATCACAAAGGATTC 
3' flank aplification for An ID 1141260 del cassette, 
Rev, flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
036 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCGTATTGGCTTAACCCACCCT 
5' flank aplification for An ID 1121140 del cassette, For, 
flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
037 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGCGAGTGATTCTTCGATTATA 
5' flank aplification for An ID 1121140 del cassette, 
Rev, flank for pyrG (pPEEL-002) 
oPEEL-
038 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACCAGTAACAGTAATCGTAGCAG 
3' flank aplification for An ID 1121140 del cassette, For, 
flank for pyrG (pPEEL-002) 
oPEEL-
039 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCACGGCGCCAATGAGATATGC 
3' flank aplification for An ID 1121140 del cassette, 
Rev, flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
040 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCCTAAGCTTTAGCTACAAGCA 
5' flank aplification for An ID39114 (AMP ligase) 
cassette, For, flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
041 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGCGTTGTTACATATAGAAGCA 
5' flank aplification for An ID39114 (AMP ligase) del 
cassette, Rev, flank for pyrG (pPEEL-002) 
oPEEL-
042 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACGTGGTCTATGTTGGATAGAT 
3' flank aplification for An ID39114 (AMP ligase) del 
cassette, For, flank for pyrG (pPEEL-002) 
oPEEL-
043 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCTCCCAGTCCTCATCATCATC 
3' flank aplification for An ID39114 (AMP ligase) del 
cassette, Rev, flank for EcoRI/BamHI dig pPEEL-001 
oPEEL-
044 CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCCGACCGATGGACACTCTTGT 
5' flank aplification for An ID1170646 cassette, For, 
flank for EcoRI/BamHI dig pPEEL-001 
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oPEEL-
045 CTGGTATAGCCAAACATCGCCAATCACCTCAATCACCCGGTGTAGGCAAAGGGTGAGAGT 
5' flank aplification for An ID1170646 del cassette, Rev, 
flank for pyrG (pPEEL-002) 
oPEEL-
046 GCCATGCGGGCTTGGGACGCCATGTCCGTCGCGTGATAACCATTGGCTTCGCGCTGAAAT 
3' flank aplification for An ID1170646 del cassette, For, 
flank for pyrG (pPEEL-002) 
oPEEL-
047 AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCGCAAAGCAGACGTTAAGCCC 
3' flank aplification for An ID 1170646 del cassette, 
Rev, flank for EcoRI/BamHI dig pPEEL-001 
 
Table 2 List of primers used for Aspergillus niger colony PCR to verify the correct integration of the deletion cassette. Primers are used to amplify the 
5’ flanking region of the cassette around 1.5 kb (the primers anneal to the beginning of pyrG selection marker and outside 5’ flank), part of the open 
reading frame (ORF) of the gene around 700 bp and 3’ flanking region around 1.6-1.7 kb (the primers anneal to the end of pyrG selection marker and 
outside 3’ flank). 
Primer 
name Sequence Usage 
oPEEL-001 AGCTGGTATAGCCAAACATC Rev primer for A. niger pyrG, anneals at promoter region 
oPEEL-006 GTAACACAAGAGAGGCAGAC For primer for checking 1162477 deletion in A. niger, should be used with oPEEL-001 
oPEEL-011 GCTAATACGTGGTATGTATG For primer for checking ID1146483 (dgdB) deletion in A. niger, should be used with oPEEL-001 
oPEEL-021 GAAGGCAGGATTGGAGAAGG For primer upstream from An ID 1090836 del cas 5'flank in An gDNA, can be used for A. niger colony PCR 
oPEEL-028 CACGTGCTACGCCAGGTAC For primer upstream from An ID 1117792 del cas 5'flank in An gDNA, can be used for A. niger colony PCR 
oPEEL-029 GTAGCATGGAGGTAAAGTAT For primer for checking ID39114 (AMP ligase) deletion in A. niger, should be used with oPEEL-001 
oPEEL-030 CAGCTATGCTACAGTATATC For primer for checking ID1121140 (FAD enzyme) deletion in A. niger, should be used with oPEEL-001 
oPEEL-035 CAAGCTACTATCGAGCACTC For primer for checking ID1141260 deletion in A. niger, should be used with oPEEL-001 
oPEEL-048 GTAGACTACCAAGTCGTAGT For primer for checking 1170646 deletion in A. niger, should be used with oPEEL-001 or -023 
oPEEL-059 TTGAGCTCGTGTGTCTGGAC For checking mixed population. Amplify ORF ID 39114, FOR 
oPEEL-060 ACAGCGGCTAGATAACGAGC For checking mixed population. Amplify ORF ID 39114, REV 
oPEEL-061 GATACATGGGCAGCGATGGA For checking mixed population. Amplify ORF ID 1090836, FOR 
oPEEL-062 CTCTCCTCACCCACCTCTGA For checking mixed population. Amplify ORF ID 1090836, REV 
oPEEL-063 ATGACCATCACCGAACCCAC For checking mixed population. Amplify ORF ID 1117792, FOR 
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oPEEL-064 GGCTCGCGCAAACTGAATAG For checking mixed population. Amplify ORF ID 1117792, REV 
oPEEL-065 CAAGGTCATCGTCGCGGATA For checking mixed population. Amplify ORF ID 1141260, FOR 
oPEEL-066 CCAACGGCACATTTCCGATG For checking mixed population. Amplify ORF ID 1141260, REV 
oPEEL-067 GCATAGCAGTGCTTCTTCGC For checking mixed population. Amplify ORF ID 1121140, FOR 
oPEEL-068 CTCCGTTGTTCACTCCGTCA For checking mixed population. Amplify ORF ID 1121140, REV 
oPEEL-069 AGTAGATTCCACACGCGGTC For checking mixed population. Amplify ORF ID 1162477, FOR 
oPEEL-070 GCCAACGTATCCCTCACCAA For checking mixed population. Amplify ORF ID 1162477, REV 
oPEEL-071 GCTGGCTTTTCGTCAAGGTG For checking mixed population. Amplify ORF ID 1146483, FOR 
oPEEL-072 GCTTGATAGCTTCGGGGTGT For checking mixed population. Amplify ORF ID 1146483, REV 
oPEEL-073 GCCCATAATCCTCCACCTCG For checking mixed population. Amplify ORF ID 1170646, FOR 
oPEEL-074 CAGTCAACGGACAATGCACC For checking mixed population. Amplify ORF ID 1170646, REV 
oPEEL-088 CCCCTATACCCGTCTGTTTG For primer for checking deletion in A. niger, binds to the end of pyrG 
oPEEL-089 CCATGGCATCCTCGAGCTCC Rev primer for checking deletion ID 39114 in A. niger, used with oPEEL-088, ~1.7 kb 
oPEEL-090 GTTGTTCATCGATTCCCCCG Rev primer for checking deletion ID 1090836 in A. niger, used with oPEEL-088, ~1.7 kb 
oPEEL-091 CATCCTCGACTGCAGCAATG Rev primer for checking deletion ID 1117792 in A. niger, used with oPEEL-088, ~1.7 kb 
oPEEL-092 CGTACTGTCAGAGCAACCGA Rev primer for checking deletion ID 1141260 in A. niger, used with oPEEL-088, ~1.7 kb 
oPEEL-093 CCGGGGGTAATAGTAGTCGC Rev primer for checking deletion ID 1121140 in A. niger, used with oPEEL-088, ~1.7 kb  
oPEEL-094 CATACTGGATTCTGTGGGCC Rev primer for checking deletion ID 1162477 in A. niger, used with oPEEL-088, ~1.6 kb  
oPEEL-095 GTGCTCTTCTAGGTTCCGAG Rev primer for checking deletion ID 1146483 in A. niger, used with oPEEL-088, ~ 1.7 kb  
oPEEL-096 GGCGGCACCGTCCGTGTGTG Rev primer for checking deletion ID 1170646 in A. niger, used with oPEEL-088, ~1.7 kb  
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Table 3 List of primers to amplify open reading frame (ORF) of the gene for expression in heterologous host and to sequence the ORF. 
Primer name Sequence Usage 
oPEEL-049 CTAGAATTCAACAAAATGCTCTCCACAATCGCACC Amplification of An ID 39114 ORF (AMP ligase) with EcoRI site, for 
oPEEL-050 CTTGGATCCTCAAACCCACGCAACGTCCC Amplification of An ID 39114 ORF (AMP ligase) with BamHI site, rev 
oPEEL-075 GCTCGGCTGCTGTAACAGGG Sequencing primer 1 ORF ID 39114 (AMP ligase) 
oPEEL-076 GCGAGTACCTGAGCTAGTCA Sequencing primer 2 ORF ID 39114 (AMP ligase) 
oPEEL-077 GCGATTCGAAGAACGCTTTC Sequencing primer 3 ORF ID 39114 (AMP ligase) 
oPEEL-078 GCGTTCCATACTCGTCCAGA Sequencing primer 4 ORF ID 39114 (AMP ligase) 
oPEEL-079 CCCGCAACCTTCAACTTCTG Sequencing primer 5 ORF ID 39114 (AMP ligase) 
oPEEL-145 AAAAAGAATTCAACAAAATGGCATTAAACCGTACCTT Amplification of ID 1090836 ORF with EcoRI site, for 
oPEEL-146 TTTGGATCCCTAAGCCTTCGCCTTCAGCA Amplification of ID 1090836 ORF with BamHI site, rev 
oPEEL-151 AAAAAGAATTCAACAAAATGGGCTCATCATTATCCTC Amplification of ID 1121140 ORF with EcoRI site, for 
oPEEL-152 TTTGGATCCTCACACCTCTTGCTTCACAT Amplification of ID 1121140 ORF with BamHI site, rev 
oPEEL-164 GCGCTGGGGAATTACACCTC Sequencing primer 1 ORF ID 1121140 
oPEEL-165 GCCCAGACTACCAGCGGGCC Sequencing primer 2 ORF ID 1121140 
OK19 CTATTTTCCCTTCTTACG Sequencing primer, binding p2159, 102 bp upstream EcoRI restriction site, for 
OK20 CGTTCATTGTTCCTTATTC Sequencing primer, binding p2159, 27 bp downstream BamHI restriction site, rev 
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Table 4 List of oligonucleotides or primers used for constructing galactaric acid producing Aspergillus niger strain. Guide RNA (gRNA) were used in 
CRISPR/Cas9 system to create double-stranded beak to the genes gaaA and gaaC. Gene udh was integrated to gaaA and gaaC locus in Aspergillus 
niger. Primers oPEEL-086 and -087 were used for colony PCR to confirm the deletion of gaaA and gaaCI and integration of uhd. 
Primer name Sequence Usage 
oPEEL-051 GCTGCAAGGCGATTAAGTTG 
Amplification of gpdAp-udh-hph from B6042 for the 
gaaA/C integration cassette, FOR 
oPEEL-052 CAATACGCAAACCGCCTCTC 
Amplification of gpdAp-udh-hph from B6042 for the 
gaaA/C integration cassette, REV 
oPEEL-053 
CCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGGCGGCCGCACTTGCACTGGAAGAGC
GTT 
5'flank amplification for udh gaaA/C integration 
cassette, flank for EcoRI/BamHI dig pPEEL-001, FOR 
oPEEL-054 GGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCATCTTCAACCTCTGGAGCGC 
5'flank amplification for udh gaaA/C integration 
cassette, flank for udh hph cassette, REV 
oPEEL-055 
TGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGAGAGAAGCTTGTATGTAATTACTTT
GT 
3'flank amplification for udh gaaA/C integration 
cassette, flank for udh hph cassette, FOR 
oPEEL-056 
AGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCGCGGCCGCGTTAATTCCCTTAGCGC
GGCT 
3'flank amplification for udh gaaA/C integration 
cassette, flank for EcoRI/BamHI dig pPEEL-001, REV 
oPEEL-080 TAATACGACTCACTATAGTGTAATTACTTTGTTATGTA gaaA gRNA for 
oPEEL-081 TTCTAGCTCTAAAACTACATAACAAAGTAATTACA gaaA gRNA rev 
oPEEL-082  TAATACGAGTCACTATAGTCATAATCTATATGATACAA gaaC gRNA for 
oPEEL-083 TTCTAGCTCTAAAACTTGTATCATATAGATTATGA gaaC gRNA rev 
oPEEL-084 
CGACCCCACTGATTTCAGTTCTACTGCAGATACACACACGCCTCGGAAACCCTTCTATTCCTGTACA
GTGACCGGTGACT udh with gaaA/C flanks for, fragment is ~2.5kb 
oPEEL-085 
TTGTCGCAAACCTGCATGTTCACCGCAACAGATGGACCAGAATCATAAACGGTCATACAGGTGGA
GATGTGGAGTGGGCG udh with gaaA/C flanks rev 
oPEEL-086 CTATCAACAACCCGCCCAAG 5´out gaaA/C del for 
oPEEL-087 AGCACAGCTGCAGCATTAAG 3' out gaaA/C del rev 
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Table 5 List of oligonucleotides for synthesizing guide RNA (gRNA) needed in CRISPR/Cas9 system in vitro using GeneArtTM Precision gRNA Synthesis 
Kit (ThermoFisher Scientific). CRISPR/Cas9 was used to delete genes. Sequences TAATACGACTCACTATAG (forward) and TTCTAGCTCTAAAAC (reverse) 
were added to the primers according to the kit. 
Primer name Sequence Usage 
oPEEL-097 TAATACGACTCACTATAGTATCACCTCCGCATAACCAT gRNA 5' 1090836 for 
oPEEL-098 TTCTAGCTCTAAAACATGGTTATGCGGAGGTGATA gRNA 5' 1090836 rev 
oPEEL-099 TAATACGACTCACTATAGAGTTCAGTCTCTGTGGAGGA gRNA 3' 1090836 for 
oPEEL-100 TTCTAGCTCTAAAACTCCTCCACAGAGACTGAACT gRNA 3' 1090836 rev 
oPEEL-101 TAATACGACTCACTATAGATGCATCCATTTTAGAGCCA gRNA 5' 1117792 for 
oPEEL-102 TTCTAGCTCTAAAACTGGCTCTAAAATGGATGCAT gRNA 5' 1117792 rev 
oPEEL-103 TAATACGACTCACTATAGTCTGGAAGTCGCTGTGCCCT gRNA 3' 1117792 for 
oPEEL-104 TTCTAGCTCTAAAACAGGGCACAGCGACTTCCAGA gRNA 3' 1117792 rev 
oPEEL-105 TAATACGACTCACTATAGTATCGCCAGAACAAAAAGCG gRNA 5' 1141260 for 
oPEEL-106 TTCTAGCTCTAAAACCGCTTTTTGTTCTGGCGATA gRNA 5' 1141260 rev 
oPEEL-107 TAATACGACTCACTATAGAGACCGATCATTATTGACGA gRNA 3' 1141260 for 
oPEEL-108 TTCTAGCTCTAAAACTCGTCAATAATGATCGGTCT gRNA 3' 1141260 rev 
oPEEL-109 TAATACGACTCACTATAGTCGTGTCTGACATTCCACAA gRNA 5' 1121140 for 
oPEEL-110 TTCTAGCTCTAAAACTTGTGGAATGTCAGACACGA gRNA 5' 1121140 rev 
oPEEL-111 TAATACGACTCACTATAGACAGAGTTCTATTCACGGGT gRNA 3' 1121140 for 
oPEEL-112 TTCTAGCTCTAAAACACCCGTGAATAGAACTCTGT gRNA 3' 1121140 rev 
oPEEL-113 TAATACGACTCACTATAGAGGACGTCATACATAAGTTC gRNA 5' 1162477 for 
oPEEL-114 TTCTAGCTCTAAAACGAACTTATGTATGACGTCCT gRNA 5' 1162477 rev 
oPEEL-115 TAATACGACTCACTATAGATACACTGGGTTGGCTTGCT gRNA 3' 1162477 for 
oPEEL-116 TTCTAGCTCTAAAACAGCAAGCCAACCCAGTGTAT gRNA 3' 1162477 rev 
oPEEL-117 TAATACGACTCACTATAGTGTTACCCCCACGCGGGGTA gRNA 5' 1146483 for 
oPEEL-118 TTCTAGCTCTAAAACTACCCCGCGTGGGGGTAACA gRNA 5' 1146483 rev 
oPEEL-119 TAATACGACTCACTATAGAGACTTGTAGGCCAGGATGT gRNA 3' 1146483 for 
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oPEEL-120 TTCTAGCTCTAAAACACATCCTGGCCTACAAGTCT gRNA 3' 1146483 rev 
oPEEL-121 TAATACGACTCACTATAGAGGCAAAGGGTGAGAGTAGT gRNA 5' 1170646 for 
oPEEL-122 TTCTAGCTCTAAAACACTACTCTCACCCTTTGCCT gRNA 5' 1170646 rev 
oPEEL-123 TAATACGACTCACTATAGAGCTCCCCCCTGCCTCCTCG gRNA 3' 1170646 for 
oPEEL-124 TTCTAGCTCTAAAACCGAGGAGGCAGGGGGGAGCT gRNA 3' 1170646 rev 
oPEEL-129 TAATACGACTCACTATAGTTCTGTCTGAGCCCGAGCTG ID 39114 5' gRNA for, cut ~541 bp 
oPEEL-130 TTCTAGCTCTAAAACCAGCTCGGGCTCAGACAGAA ID 39114 5' gRNA rev, cut ~541 bp 
oPEEL-131 TAATACGACTCACTATAGTCCACGATGCCCTACACACC ID 39114 3' gRNA for, cut ~541 bp 
oPEEL-132 TTCTAGCTCTAAAACGGTGTGTAGGGCATCGTGGA ID 39114 3' gRNA rev, cut ~541 bp 
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JGI ID 39114 IPR000873: AMP dependent synthetase and ligase (3246 bp) 
ATGCTCTCCACAATCGCACCACAACCACCCACGCTACAAGAGCCTCTGTCTAAAGACGATCATATTCTTCCTTTA
CAATCTTACGAACCCTCGACCATTGACGAGCTCGTTCGTCAGCGTGCATCACTTGGAGCCGCACAACCCATCAT
TTCTTACCCGCGGACCGGCATCGAATATGTGGACTATCCACTGCAGCAACTGGATGTCTTCGCATTCCGCGTCT
CCAAGGTGTTATCAGACCGCATTCCACCTCGGAAGTCGTCGGCTGAAACTCCCAAAGTCATCGCTTTACTGGGA
CCTTCAGATCTCAACTACCTGGTGATGCTGCTTTCACTGGCCAAATTGAGTCACAGTGGACTGCTCTTATCGACC
AGGATCTCCATAGATGCTTATGTCTCCCTGCTGGAGAGAACCGGGTCTCGACATGTTTTCATTCACAGCTCTTTC
CGAGATACCGCCGAGGAAATCAAGAAGCGAGTACCTGAGCTAGTCATTGATGAGATTCCAACTGAGGAAAAC
TATCACTATCCCATCACGGAATATGTCGACACGAATCTGGTTCCGCATCTCGACCCGAAGATTGAATCCAAGCA
CATTGCATGGATTATTCACTCCAGTGGATCGACTGGGCTTCCGAAACCTATCTTTCATACGCAATCTGCTGCGCT
GAAGAACTACTCCGGACATATGAACATGTCTGGGTTTGTCACTCTGCCTCTTTATCACAACCATGGAATCAGTT
GTCTGTTCCGGACGATTCACGCTAGCAAACAGCTGCACCTGTATAATGCCAATCTCCCATTGACAAGGCAGTAC
TTGCTCGAGATCATGGGGTCCAATTCGTTTGAAGTTTTCTACGGTGTCCCCTATGCGCTGAAACTGTTGGCTGA
GACACGAGAGGGAATATCCGCTCTGGCTAAGCTAAAGGCCGTCATGTTTGGAGGCTCCGCATGCCCGGACTCT
CTGGGTAACTTGCTGGTCGAAAATGATGTTCATCTCATCAGCCACTACGGATCGTAAGTGGATTCTGCAATGTA
TTTCGGGTACTTTACTAACATATATACAGAACTGAGACCGGCCAGCTTATGATGTCGACCAGGCCTCGTGACGA
CAAGGGATGGGACTGGCTCCGTCCATCTGACACCGTCAAAAGGTTTTTGCGATTCGAAGAACGCTTTCCGGGA
GTATTTGAGCTCGTGTGTCTGGACGGCTGGCCTTCCAAGGTCATGACCAACCGACCAGACGGCTCGTACGCCA
CCAAGGACCTGTTTGTCAAGCATCCCACTATGGAAGCATACAAGTACTATGCTCGGCTAGATGATACAATCGTT
CTATATAACGGAGAGAAGGTCAACCCACTTGACCTGGAAGGACGAGTCCGACAGCGCAGCACTGTTGCCGAA
GCCATTGCATTTGGAGCAGGCAAAGCCCACATCGGGCTGGCTGTCATCCGTGCCCCTGGCACCGAGTCACTCT
CCGATGAGGATATCATTGACAGTATTTGGCCAGCTGTTGAGAAGGCTCACGAGGCACTACCTGCGTTCGGACA
GCTCTCAAAGAACATGGTTCGAGTGTTGCCTGCGGACACTCCCTATCCTCGGACTGATAAGGGCACCATCATCC
GGCAAGCATTTTACAAGAACTTCCAGCCGCTGATTGAAGAGGTTTACGCCGCTGTGGACGCCATGACGGGCAC
GCTGGTTCTGTCTGAGCCCGAGCTGAGGGACTTCCTCAAGAAGCAGCTTCTCCAGATTTTGCCCCTCAAGGATT
CCAATCTGCTGACCGACGATGCTGATTTCTTCTCCCTGGGCATGGACTCTCTGCAGGCTAGTCAGCTGCGTTCC
ATACTCGTCCAGAACTTGGACACCAAGGGCCATCAACTGGGACTTAATATTGCCTTCGAGCAGCCCACTATTTC
CTTGCTCGCTCGTTATCTAGCCGCTGTGCAGTCCGGAGAAGCCCTTCCAGGTTCTCAGCCAATCCATGAACAAA
TGCGCGCTCTCATCTCCCAATTCAGCCACTTTGAACCACACGTTCCCCATTCTAATGAGCTTCCTGGTCGTTATG
TTGTGAGTATCCCTCAACATCCAGGTCAGTACACACTGCTGACTATTCTAGGTTCTCACCGGTGCCACTGGCTCC
CTAGGCAGCCATATCGCGCACCAACTCGCACAGAACTCTTCCGTGAACAAAGTCTACTGCCTCATCCGCGCCTC
CTCCCCAATTGAAGCCTACAAGCGCCTCCACGATGCCCTACACACCCGGTACGTCTACAGCCCCCTCTCTTCTTC
CTCCAAAGCCAAGCTCATCGCCCTCCCCGCCCCAACCCTATCCCATCCAACTCTCTCCCTCCCTGAGGAAACCTA
CAACACCCTCCTCACCGAAACCACTGACATCATCCACTGCGCCTGGCCCGTCAACTTCAACCTCCAGCTCAGCA
GCTTGGCACAAGACACCCTCCCCACCCTACACAATCTTCTCTCTCTAGCCCTGAAAGCCCAGCGCCCCGAACCC
GCAACCTTCAACTTCTGCTCCTCCGTCAGCAGCGTCGTCAACAGCGCCGTCTCCCCCATCCCCGAAACTCTCCCT
GAGTCCCTCACCGCTGCACAATCAATGGGTTATGCCCAATCCAAGCTCATCGCAGAACATATCTGCGCCAACGC
CACGCCCTACCTTGATGCGCGGGTCCTCCGTATCGGGCAGATCATCGGCGATACGAAGCACGGGGTGTGGAA
TGCCACGGAGGCAATTCCGTTGATGCTTCGGGCGGCGGTTACAGTGGGGGCGTTGCCGAGGCTGGATGAGA
GGATGCGGTGGGTGCCGGTTGATGTTGTTGCTGCAGCTGTGATGGATATTACTCTTCACAAGGAGGAGCAAG
GGCTGGAAAGGAAGAAGGGGGCGGATGATGTGGAGGTGTATAACATCTTGAACCCGTATAGCTTCCATTGGA
CAAAGGATTTGCTTCCTGCTCTAAGGGCGGCCGGGTTTGGATTTGAGGATATGGAGTTCGCGGAGTGGATTAA
GCGGGTTAAGGATCTGGCAGATCCGGAGAGGAATCCGCCTGTTAAGTTGGTGGGGTTCTGGGAGGGGAAGT
ATGGAAGTGCGAAGCCATTTAGGGGATTGGAGTTTGTCACGGAGAAGGCGAGGGAGAGGGCTGAGGGGTTG
AGGGAGTTGAGTGCGGAAGGGTTGGAAGGGGGACTGGTGGGCAAGATGGTGGAGTGGTTCAGGGACGTTG
CGTGGGTTTGA 
NNNNN = exon 
NNNNN = intron 
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JGI ID 1090836 IPR001395: Aldo/keto reductase (1376 bp) 
ATGGCATTAAACCGTACCTTCAAGCTCAACACAGGCTACGACATGCCTGCCGTCGGCCTAGGAACATGGGTAT
ATCAATCGCTTTTACGCAAAACATGCCCGCTTCAGATCTGACACAATCAAACAGCAATCGAAGAAAGACGAAG
TCCGCGACGCCGTCATCGCAGCCCTGAAATGCGGCTACCGGCACATTGACGCGGCAGCAGTGTATGGCAACG
AACAGGAAGTGGGAGACGGGATGAGATTGTCTGGGGTTCCGCGGGAGGAGATTTTCGTGAGCCAGCCCTTAA
AACCTAAAGAGAGGGTTATGATATAGGGCTAACTCATGCTGAATGTATAGCTCACAAGCAAGCTATGGAATAC
CCACCACCATCCCGAAAATGTCGAAGAAGCTGTGGATAAATCGCTGGCTGATTTGCAGACTGATTATCTGGAT
CTTTATCTTGTATGTTGACGATGTGTCTACTAGCCGTTGAAGTCCTGCTAAATATTGTACAGATCCACTGGCCCG
TCGCGTTCCGATACTCAACTACCACCATCCAGCCTGTCAATGAACAAACGGGCCTGATTGACGTGGTAGACGTA
CCAATCAAAGATACATGGGCAGCGATGGAGAAACTAGTAGAGAAAGGCAAAGTCCGCTCCATCGGTGTGAGC
AACTTTACTCGCGAGAAGATCGAGGAGTTGTTGAAGACGTGAGTATGCTTGTTATTGCGTATGTATCATAGCT
GACGCTATCTACAGAGCGAAGATTACTCCCGCAGTCAACCAGATCGAGGCTCATCCGTTCCTTCAGCAGAGGG
ATCTTTTGGAGTGGTCGACGCAGAAAGTAAGATACTTTACATCTTCAACAACACGACTATCATACTAATCGAAC
TTTGTCTAGGGCATCGTGGTAGCAGGCTACTCCCCCCTAGGCAACAACATCTACAACATCCCTCGGTATGCAGA
CCGTTTCCAGCTCTTCATATCTCGCAAGAAACTGACAAACTCCCAGCGCCGTCGACGACCCCCTCGTCATCGAA
ACAGCCAAGAAATTAAACAAAACCCCTGCGCAAGTCCTCATCAGCTGGGCCGTCCAGCGCGGAACTGTCGTGC
TCCCCAAGTCCGTCACTCCGGAGAGAATCGAGAGTAATTTCCAAGGTAGTCTTTCTCCCACCCACAACATATGT
CCTCATTGTGCTAATATGGACTATTCAGATTTCGTCCTTCCCGACGATGCATTCTCAACCATTCAATCACTGGAA
CGCCACCAGCGGATGAATTTCCCGGCTAGAATCGGTGTCGATATTTTCTCAGAGGTGGGTGAGGAGAGTGTG
AGGAAGAGTGCGCTTGCTTGGGCGGAGCAGCAGAGGGTGCTGAAGGCGAAGGCTTAG 
NNNNN = exon 
NNNNN = intron 
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JGI ID 1121140 IPR006076: FAD dependent oxidoreductase (2353 bp) 
ATGGGCTCATCATTATCCTCGGTTTCCAATTCTTCTACCGAAGACATTGTCATAGTAGGCGCTGGCGCCAGTGG
CATAGCAGTGCTTCTTCGCTTGATCGAACATGCTAAGGATGGCAAGAAGATTCCTCCCATCATCGTCGTTGAGA
AAGCTTCACCTCCTGGTCCAGGACTGGCATATTCTGCCGCTTGTACCGGGACCATCCTGAACATGCACACGGAC
ACAATGGGTCTATATTATAACGACCCCAAGCATTTTACGAGATGGAGAAGCGAGCTAGCCAGTGGTCCCTTCC
CGTCCCGAAGCCAATATGGAGAGTACCTGGAGGCGATGTGGTCCGAGATACTCTCGCAAGCCCAACAGATGG
GCTTGGACATCTCAATCATCCAAGACGAAGTATCCGACATTGACCGTCATGACGACAGTACCTTCACCTTGACA
CTGACAGGGGGGCGTCGCCTTGCTGCCCAATCTGTCGTGTTGGCGCTGGGGAATTACACCTCCACTCTCAACA
CGCACCTGCTGAATCAACCGGGCTTCTTTCCCAGCCCGTGGCCAACCTCTCAACTAAAGACCATTCCCGCCGAT
GCCTCGGTCCTCATCATCGGATCAAGGCTCTCCGCTGTTGACGCAGCGCTATTTCTCTCCAAGAATGGCCACAA
GGGCCCGTTGACCTTCATGTCGCGCAGTGGCCGCCTTCCCAAAGTCCAGGGCGAGCCTGAGCCCTACCCGCGC
CGTTACACCCTTCACACCTTGGCCCGATACATCGAATCCAACCCAGCGGACGGTCTTGTCAAGCTCACAACCAC
CCTTATGGATGAAATTGACGGAGTGAACAACGGAGATTGGACCTGGATACAGAAGCATGCCTCGCCGCTCGCT
GAACTACGGGCAGACCTATTCGCGGCACAGGGAGGAAATGTCCATTGGCAAACCGTCCTCCGCCACACGGCC
CCAGTAATCGAGCGTTACTGGCACTGTTTGCCTCTAGAAAGCCAGAAGCTATTCATGGCCAAATTCTTCACTCC
TTGGATGCGATATCGTCACGGAATGCCGGTGCAGAATGCGCAAAAGATACTCAACCTGATGGAAACCTCCCAA
CTTAGTGTCGTCGCAGGAGAGGCTGTCCACTGGGATGAGGGTGAGGGCGCCTTCATCGCCCAGACTACCAGC
GGGCCCATAGAAGCATCCTATGTCATCGAAGCAACTGGACAAGAGAGTCATCTCGATCGCATCCCATCTCCGC
TCGTCCAGTCCGCTGTCCGAAAAGGATTATTCACCCCACACCCGATGGGTGGGGTTGACGTCGACTTCCACACC
CTCTGTACATCAACACCCGGCCTATACACTATGGGCTCGTTGACCCGCGGCACGCACTTCTACGTCAGCGCCAT
CGATCGAACGGCTGCCCATGCGGCTCGCATCGCCGACGCACTGGTCGGGGAGCCCCCTGCCAGACCTGTACAT
ATCGCGATCTTTCTCGGTGCAGACGTGGCCTCGCACCTGATAGCCAGTGACCTGGTCCCCCTGCTTCTGGCCGA
GGGCCATATGCCTTTCCTCTTTTTGTCATCCAGCAAGCAGACACCTTCCTTAGAGGGGTCTGATAGTCGACCTTT
CGACCTGCGCAAACTGGAATTTTTCGAACGCGAGCTTTTCCGCAAGCATCTCTGTCCAAGATTGAAGGAACACA
GTTTCAAAGGCGCACGGCACATGACCGTTGAGCAGATGCAGACGGCATACGGGGTCCTTGTGCAAGAAATAC
CAGACACGAAGGGTGCCTCGGTCGGCAGAATGTTGCAAAAATACTTCATCGACGTCGGCATATCACTGACATG
CGCCGAGGCACCCGACCAGGATGTTATTGCTTACTTATCCTCTTCGTCGCGCCACCTTCTAGCAGTGGATGCCG
GCGTCCTCTCGGCTCCTTGGGACAGCAAGAAAGCTGGAGCCAAGTTTGGGTATACCCTTCGTGAATTTCATGA
AGACGGTAAGTTAGGAGACGTGATTGATCGCCGGACTATTCCCGTCGGGGAGTCCGCGGCCATGCTGACAGG
TGTGGGCAAGGAGTATGCGCTTGGAGTGCAGATGGCTGTTGATGCAATTAAGCTGGTGAGTCGGGGAAAGCC
TTTGAGCGACGTTGCTTGTCCTCGATCTAGCGATACTTCCCGCCATTGTTATTTGTCCGCGGAGGAGTTGTGGA
AATATTGTCATGAGAGAAGAATTGAACTGGTGGATGATAAGAGGGTTGTGGAAATGCTGGTGGAGTCATTTG
CCCCGCTGGAAAAGAGGGAGGTGCTGCGAAAGGAGCTGGACGAGGCGGTGCAGGAATGGTATGTGAAGCA
AGAGGTGTGA 
NNNNN = exon 
NNNNN = intron 
 
 
